Evaluated across numerous clinical trials spanning Early Phase 1 through Phase 4, doxorubicin hydrochloride serves as a foundational chemotherapeutic agent for oncology indications including female and metastatic breast cancer, ovarian neoplasms, leiomyosarcoma, non-Hodgkin lymphoma, AIDS-related Kaposi sarcoma, and multiple myeloma. Sponsored by diverse entities—including academic institutions, pharmaceutical developers, and federal agencies—these studies encompass recruiting, active not recruiting, and completed trials focused on combination regimens and side-effect mitigation.
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT07220187 | NOT_YET_RECRUITING | Richter Syndrome; Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma; Transformed Small Lymphocytic Lymphoma to Diffuse Large B-Cell Lymphoma |
SWOG Cancer Research Network |
2026-08-31 | PHASE3 |
| NCT07072585 | NOT_YET_RECRUITING | Stage II T Lymphoblastic Leukemia/Lymphoma; Stage III T Lymphoblastic Leukemia/Lymphoma; Stage IV T Lymphoblastic Leukemia/Lymphoma; T Acute Lymphoblastic Leukemia; T Lymphoblastic Lymphoma |
Children's Oncology Group |
2026-08-28 | PHASE2; PHASE3 |
| NCT06947967 | RECRUITING | Lymphoma, T-Cell, Peripheral |
Chipscreen Biosciences, Ltd. |
2025-08-12 | PHASE3 |
| NCT05283720 | ACTIVE_NOT_RECRUITING | Non-Hodgkin Lymphoma |
Genmab |
2022-06-14 | PHASE2 |
| NCT07321912 | RECRUITING | Osteosarcoma; Ewing Sarcoma |
Milton S. Hershey Medical Center |
2026-06-05 | PHASE2 |
| NCT07662928 | NOT_YET_RECRUITING | Adult Burkitt Lymphoma |
AIDS Malignancy Consortium |
2026-09-17 | PHASE2 |
| NCT05675410 | RECRUITING | Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 |
National Cancer Institute (NCI) |
2023-05-11 | PHASE3 |
| NCT07636564 | NOT_YET_RECRUITING | Acute Leukemia of Ambiguous Lineage; B Acute Lymphoblastic Leukemia; B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative; T Acute Lymphoblastic Leukemia |
SWOG Cancer Research Network |
2026-10-14 | PHASE2 |
| NCT05605899 | ACTIVE_NOT_RECRUITING | High-risk Large B-cell Lymphoma (LBCL) |
Kite, A Gilead Company |
2023-02-10 | PHASE3 |
| NCT07517419 | ENROLLING_BY_INVITATION | Gastric Cancer Peritoneal Metastases |
Chinese University of Hong Kong |
2021-10-11 | PHASE2 |
| NCT07712588 | NOT_YET_RECRUITING | Diffuse Large B-Cell Lymphoma (DLBCL) |
Dizal Pharmaceuticals |
2026-09 | PHASE2; PHASE3 |
| NCT07654426 | RECRUITING | Diffuse Large B-cell Lymphoma (DLBCL); Cardiotoxicity; Lymphoma |
Beth Israel Deaconess Medical Center |
2026-08-31 | PHASE2 |
| NCT07551583 | RECRUITING | Hodgkin Lymphoma |
M.D. Anderson Cancer Center |
2026-08-19 | PHASE2 |
| NCT01042379 | RECRUITING | Breast Neoplasms; Breast Cancer; Breast Tumors; Angiosarcoma; TNBC - Triple-Negative Breast Cancer; HER2-positive Breast Cancer; HER2-negative Breast Cancer; Hormone Receptor Positive Tumor; Hormone Receptor Negative Tumor; Early-stage Breast Cancer; Locally Advanced Breast Cancer |
QuantumLeap Healthcare Collaborative |
2010-03-01 | PHASE2 |
| NCT05371093 | ACTIVE_NOT_RECRUITING | Relapsed/Refractory Follicular Lymphoma |
Kite, A Gilead Company |
2022-09-22 | PHASE3 |
| NCT07227584 | RECRUITING | Acute Lymphoblastic Leukemia; Philadelphia Chromosome-Negative Lymphoblastic Leukemia; Acute Lymphoblastic Leukemia (ALL); Leukemia |
Dana-Farber Cancer Institute |
2026-04-03 | PHASE2 |
| NCT07719855 | NOT_YET_RECRUITING | Follicular Lymphoma ( FL) |
Ruijin Hospital |
2026-07 | PHASE3 |
| NCT05691478 | SUSPENDED | High Grade Osteosarcoma; Localized Osteosarcoma; Metastatic Osteosarcoma; Secondary Osteosarcoma |
National Cancer Institute (NCI) |
2023-03-03 | PHASE2; PHASE3 |
| NCT07064018 | RECRUITING | Soft-tissue Sarcoma; Triple Negative Breast Cancer; Non-small Cell Lung Cancer; Cervical Cancer; Ovarian Cancer; KRAS Mutation-Related Tumors |
University of California, Irvine |
2025-04-30 | PHASE1; PHASE2 |
| NCT07565324 | NOT_YET_RECRUITING | HER-2 Positive Breast Cancer |
National Taiwan University Hospital |
2026-04-30 | PHASE2 |
| NCT05411237 | NOT_YET_RECRUITING | Kaposi Sarcoma; HIV-1-infection; AIDS-related Kaposi Sarcoma |
AIDS Malignancy Consortium |
2026-09 | PHASE3 |
| NCT06528496 | RECRUITING | High-risk Neuroblastoma; Neuroblastoma; Childhood Neuroblastoma |
Memorial Sloan Kettering Cancer Center |
2024-07-22 | PHASE2 |
| NCT06486441 | ACTIVE_NOT_RECRUITING | Endometrial Cancer |
Gilead Sciences |
2024-08-28 | PHASE3 |
| NCT06245889 | RECRUITING | Triple Negative Breast Cancer |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2024-05-01 | PHASE2 |
| NCT05848765 | RECRUITING | Relapsed Follicular Lymphoma; Refractory Follicular Lymphoma |
University of Birmingham |
2023-09-04 | PHASE2 |
| NCT07504588 | NOT_YET_RECRUITING | Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma; Recurrent Platinum-Sensitive Fallopian Tube High Grade Serous Adenocarcinoma; Recurrent Platinum-Sensitive Ovarian High Grade Endometrioid Adenocarcinoma; Recurrent Platinum-Sensitive Ovarian High Grade Serous Adenocarcinoma; Recurrent Platinum-Sensitive Primary Peritoneal Endometrioid Adenocarcinoma; Recurrent Platinum-Sensitive Primary Peritoneal High Grade Serous Adenocarcinoma |
National Cancer Institute (NCI) |
2026-09-10 | PHASE2 |
| NCT06188676 | RECRUITING | Primary Mediastinal Lymphoma |
National Research Center for Hematology, Russia |
2022-04-01 | PHASE3 |
| NCT07463313 | NOT_YET_RECRUITING | Thymoma and Thymic Carcinoma |
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine |
2026-03 | PHASE2; PHASE3 |
| NCT06829199 | WITHDRAWN | Early Triple Negative Breast Cancer |
Merck Sharp & Dohme LLC |
2025-03-26 | PHASE2 |
| NCT04199026 | RECRUITING | Metastatic Sarcoma; Recurrent Sarcoma; Resectable Sarcoma |
M.D. Anderson Cancer Center |
2025-02-25 | |
| NCT01419561 | RECRUITING | KSHV Inflammatory Cytokine Syndrome (KICS); KSHV; HHV-8 |
National Cancer Institute (NCI) |
2011-09-08 | PHASE2 |
| NCT07218809 | RECRUITING | Epithelial Ovarian Cancer |
AstraZeneca |
2025-12-29 | PHASE3 |
| NCT03934905 | RECRUITING | Anthracycline Related Cardiotoxicity in Breast Cancer |
Texas Tech University Health Sciences Center |
2022-06-01 | PHASE1; PHASE2 |
| NCT07213804 | RECRUITING | Ovarian Neoplasms; Fallopian Tube Neoplasms; Peritoneal Neoplasms; Neoplasm Metastasis |
Eli Lilly and Company |
2025-10-22 | PHASE3 |
| NCT07016399 | RECRUITING | Anatomic Stage II Breast Cancer AJCC v8; Anatomic Stage IIIA Breast Cancer AJCC v8; Triple-Negative Breast Carcinoma |
Vandana Abramson |
2025-09-09 | PHASE2 |
| NCT07224100 | RECRUITING | B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1; B Lymphoblastic Leukemia/Lymphoma With t(9;22)(q34.1;q11.2); BCR-ABL1; Lymphoblastic Lymphoma |
University of Washington |
2026-03-30 | PHASE2 |
| NCT06204614 | ENROLLING_BY_INVITATION | Muscle Invasive Bladder Urothelial Carcinoma |
Brigham and Women's Hospital |
2024-06-14 | EARLY_PHASE1 |
| NCT05711628 | WITHDRAWN | Recurrent Classic Hodgkin Lymphoma; Refractory Classic Hodgkin Lymphoma |
National Cancer Institute (NCI) |
2023-08-10 | PHASE3 |
| NCT05389423 | RECRUITING | Diffuse Large Cell Lymphoma; Non-Hodgkin Lymphoma; Burkitt Lymphoma; Plasmablastic Lymphoma; B-Cell Neoplasm |
National Cancer Institute (NCI) |
2023-06-27 | PHASE1 |
| NCT04811703 | RECRUITING | Metastatic Ovarian Carcinoma; Peritoneal Carcinomatosis; Stage III Ovarian Cancer; Stage IV Ovarian Cancer; Stage III Fallopian Tube Cancer; Stage IV Fallopian Tube Cancer; Metastatic Malignant Neoplasm in the Peritoneum |
Hospices Civils de Lyon |
2021-07-30 | PHASE1 |
| NCT03984448 | ACTIVE_NOT_RECRUITING | Diffuse Large B-Cell Lymphoma; Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; Double-Expressor Lymphoma; EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; High Grade B-Cell Lymphoma, Not Otherwise Specified; Neoplastic Cells With Double Expression of MYC and BCL2 Proteins Present; Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma |
National Cancer Institute (NCI) |
2019-10-22 | PHASE2; PHASE3 |
| NCT07486310 | NOT_YET_RECRUITING | Advanced Gastric Cancer |
Guangdong Provincial People's Hospital |
2026-03-01 | PHASE2 |
| NCT06091254 | RECRUITING | Follicular Lymphoma (FL) |
Regeneron Pharmaceuticals |
2023-12-12 | PHASE3 |
| NCT07676175 | NOT_YET_RECRUITING | Previously Untreated Peripheral T-Cell Lymphoma |
BeBetter Med Inc |
2026-07-01 | PHASE2 |
| NCT07049848 | RECRUITING | Soft Tissue Sarcoma |
M.D. Anderson Cancer Center |
2025-09-11 | PHASE2 |
| NCT03719105 | RECRUITING | NK-Cell Lymphoma; NK-Cell Leukemia; Peripheral T Cell Lymphoma |
New York Medical College |
2019-03-01 | EARLY_PHASE1 |
| NCT06849986 | RECRUITING | Soft Tissue Sarcomas; Angiosarcoma; Fibrosarcoma; Leiomyosarcoma; Pleomorphic Liposarcoma; Malignant Peripheral Nerve Sheath Tumor (MPNST); Desmoplastic Small Round Cell Tumor |
Fudan University |
2025-02-25 | PHASE2 |
| NCT05610735 | RECRUITING | Recurrent Ovarian Cancer |
Sham Sunder Kakar |
2024-09-25 | PHASE1; PHASE2 |
| NCT06297512 | RECRUITING | Glioblastoma |
Iacopo Sardi |
2022-12-09 | PHASE2 |
| NCT05748834 | RECRUITING | Breast Cancer |
SCRI Development Innovations, LLC |
2023-07-24 | PHASE2 |
| NCT01424982 | ACTIVE_NOT_RECRUITING | Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Acute Lymphoblastic Leukemia; Adult Acute Lymphoblastic Leukemia in Complete Remission; B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1; Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Philadelphia Chromosome Positive; Untreated Adult Acute Lymphoblastic Leukemia |
M.D. Anderson Cancer Center |
2011-10-05 | PHASE2 |
| NCT05404945 | ACTIVE_NOT_RECRUITING | Classical Hodgkin Lymphoma |
University of Virginia |
2022-07-26 | PHASE2 |
| NCT03914625 | ACTIVE_NOT_RECRUITING | B Acute Lymphoblastic Leukemia; B Lymphoblastic Lymphoma; Down Syndrome |
National Cancer Institute (NCI) |
2019-07-03 | PHASE3 |
| NCT05949021 | ACTIVE_NOT_RECRUITING | Triple Negative Breast Cancer (TNBC) |
Mridula George, MD |
2023-10-07 | PHASE2 |
| NCT06318897 | RECRUITING | Stage 1 cT1b-T1cN0M0; Triple Negative Breast Cancer |
M.D. Anderson Cancer Center |
2024-05-29 | PHASE2 |
| NCT06006117 | RECRUITING | Marginal Zone Lymphoma |
The Lymphoma Academic Research Organisation |
2023-09-05 | PHASE3 |
| NCT05774275 | RECRUITING | High-Risk Localized Soft Tissue Sarcoma |
Fudan University |
2022-08-25 | PHASE1; PHASE2 |
| NCT05020860 | RECRUITING | Breast Cancer; Breast Neoplasm; Breast Cancer Female; Breast Cancer Invasive; Breast Cancer Stage II; Breast Cancer Stage III; Triple Negative Breast Cancer; Hormone Receptor-positive Breast Cancer; HER2-positive Breast Cancer; Triple Negative Breast Neoplasms; Estrogen Receptor-positive Breast Cancer |
Baylor Breast Care Center |
2023-04-18 | PHASE2 |
| NCT06815575 | RECRUITING | Solid Tumours; Advanced Solid Tumours |
Racura Oncology Ltd |
2025-04-02 | PHASE1 |
| NCT06312176 | RECRUITING | Breast Neoplasms |
Merck Sharp & Dohme LLC |
2024-04-14 | PHASE3 |
| NCT05279300 | SUSPENDED | Advanced Solid Tumor; Advanced Lymphoma |
CStone Pharmaceuticals |
2022-03-28 | PHASE1 |
| NCT04301076 | RECRUITING | Acute Adult T-Cell Leukemia/Lymphoma; Adult T-Cell Leukemia/Lymphoma; Chronic Adult T-Cell Leukemia/Lymphoma; HTLV-1 Infection |
National Cancer Institute (NCI) |
2021-08-31 | PHASE1 |
| NCT06994195 | RECRUITING | Epithelial Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Cancer |
Sichuan Baili Pharmaceutical Co., Ltd. |
2025-08-04 | PHASE3 |
| NCT05578976 | ACTIVE_NOT_RECRUITING | Diffuse Large B-Cell Lymphoma |
Genmab |
2023-02-08 | PHASE3 |
| NCT04803201 | RECRUITING | Angioimmunoblastic T-cell Lymphoma; Enteropathy-Associated T-Cell Lymphoma; Follicular T-Cell Lymphoma; Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma; Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma; Nodal Peripheral T-Cell Lymphoma With TFH Phenotype; Peripheral T-Cell Lymphoma, Not Otherwise Specified |
Alliance for Clinical Trials in Oncology |
2021-10-08 | PHASE2 |
| NCT07081022 | ACTIVE_NOT_RECRUITING | B-cell Non-Hodgkin's Lymphoma |
Shanghai Junshi Bioscience Co., Ltd. |
2025-08-17 | PHASE2 |
| NCT06377566 | RECRUITING | Hodgkin Lymphoma |
Memorial Sloan Kettering Cancer Center |
2024-04-17 | PHASE2 |
| NCT01840592 | ACTIVE_NOT_RECRUITING | Hepatocellular Carcinoma |
Memorial Sloan Kettering Cancer Center |
2013-04 | PHASE2 |
| NCT05377905 | RECRUITING | Cutaneous Squamous Cell Carcinoma; Skin Cancers - Squamous Cell Carcinoma |
Falo, Louis, MD |
2023-09-13 | PHASE1; PHASE2 |
| NCT03710772 | ACTIVE_NOT_RECRUITING | Mantle Cell Lymphoma |
M.D. Anderson Cancer Center |
2019-05-01 | PHASE2 |
| NCT04799275 | ACTIVE_NOT_RECRUITING | Ann Arbor Stage III Diffuse Large B-Cell Lymphoma; Ann Arbor Stage IIX (Bulky) Diffuse Large B-Cell Lymphoma; Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma; Diffuse Large B-Cell Lymphoma Activated B-Cell Type; Diffuse Large B-Cell Lymphoma Associated With Chronic Inflammation; Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type; Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; Grade 3b Follicular Lymphoma; HHV8-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements; High Grade B-Cell Lymphoma, Not Otherwise Specified; Intravascular Large B-Cell Lymphoma; Lymphoplasmacytic Lymphoma; Nodular Lymphocyte Predominant B-Cell Lymphoma; Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type; T-Cell/Histiocyte-Rich Large B-Cell Lymphoma; Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma; Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma |
National Cancer Institute (NCI) |
2021-05-20 | PHASE2; PHASE3 |
| NCT04978584 | ACTIVE_NOT_RECRUITING | Diffuse Large B-Cell Lymphoma |
M.D. Anderson Cancer Center |
2022-03-03 | PHASE2 |
| NCT01970722 | ACTIVE_NOT_RECRUITING | FIGO Stage IVA Ovarian Cancer; FIGO Stage IVB Ovarian Cancer; Platinum-Resistant Ovarian Carcinoma; Recurrent Fallopian Tube Carcinoma; Recurrent Ovarian Carcinoma; Recurrent Primary Peritoneal Carcinoma; Recurrent Uterine Corpus Carcinoma; Stage III Fallopian Tube Cancer AJCC v7; Stage III Ovarian Cancer AJCC v6 and v7; Stage III Primary Peritoneal Cancer AJCC v7; Stage III Uterine Corpus Cancer AJCC v7; Stage IIIA Fallopian Tube Cancer AJCC v7; Stage IIIA Ovarian Cancer AJCC v6 and v7; Stage IIIA Primary Peritoneal Cancer AJCC v7; Stage IIIA Uterine Corpus Cancer AJCC v7; Stage IIIB Fallopian Tube Cancer AJCC v7; Stage IIIB Ovarian Cancer AJCC v6 and v7; Stage IIIB Primary Peritoneal Cancer AJCC v7; Stage IIIB Uterine Corpus Cancer AJCC v7; Stage IIIC Fallopian Tube Cancer AJCC v7; Stage IIIC Ovarian Cancer AJCC v6 and v7; Stage IIIC Primary Peritoneal Cancer AJCC v7; Stage IIIC Uterine Corpus Cancer AJCC v7; Stage IV Fallopian Tube Cancer AJCC v6 and v7; Stage IV Ovarian Cancer AJCC v6 and v7; Stage IV Primary Peritoneal Cancer AJCC v7; Stage IV Uterine Corpus Cancer AJCC v7; Stage IVA Uterine Corpus Cancer AJCC v7; Stage IVB Uterine Corpus Cancer AJCC v7 |
City of Hope Medical Center |
2014-05-19 | PHASE1 |
| NCT03755804 | ACTIVE_NOT_RECRUITING | Hodgkin Lymphoma |
St. Jude Children's Research Hospital |
2018-12-12 | PHASE2 |
| NCT04874311 | ACTIVE_NOT_RECRUITING | Advanced Soft-tissue Sarcoma; Metastatic Soft-tissue Sarcoma |
Institut Bergonié |
2022-03-01 | PHASE2 |
| NCT03937830 | ACTIVE_NOT_RECRUITING | Hepatocellular Cancer; Hepatocellular Carcinoma; Metastatic Hepatocellular Carcinoma |
National Cancer Institute (NCI) |
2021-03-10 | PHASE2 |
| NCT04638790 | RECRUITING | Hodgkin Lymphoma, Adult |
State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia |
2020-02-01 | PHASE3 |
| NCT07635342 | RECRUITING | HER2-positive Breast Cancer |
Hebei Medical University Fourth Hospital |
2024-04-30 | PHASE2 |
| NCT06526923 | RECRUITING | Cystic Fibrosis |
Spirovant Sciences, Inc. |
2024-09-16 | PHASE1; PHASE2 |
| NCT04759586 | ACTIVE_NOT_RECRUITING | Primary Mediastinal Large B-Cell Lymphoma |
National Cancer Institute (NCI) |
2021-10-05 | PHASE3 |
| NCT06751485 | NOT_YET_RECRUITING | Ovarian Cancer; Primary Peritoneal; Fallopian Tube Cancers |
Jiangsu Alphamab Biopharmaceuticals Co., Ltd |
2025-01-15 | PHASE3 |
| NCT05281471 | RECRUITING | Platinum-resistant Ovarian Cancer; Platinum-refractory Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Cancer; High-grade Serous Ovarian Cancer; Endometrioid Ovarian Cancer; Ovarian Clear Cell Carcinoma |
Genelux Corporation |
2022-08-31 | PHASE3 |
| NCT03805022 | RECRUITING | Non-metastatic Soft-tissue Sarcoma; Resectable |
Institut Bergonié |
2019-02-14 | PHASE3 |
| NCT01025089 | ACTIVE_NOT_RECRUITING | Thymoma; Thymic Carcinoma; Clinical Masaoka Stage II to IVA |
Memorial Sloan Kettering Cancer Center |
2009-12 | PHASE2 |
| NCT05711615 | RECRUITING | Metastatic Dedifferentiated Liposarcoma; Metastatic Leiomyosarcoma; Metastatic Myxofibrosarcoma; Metastatic Sarcoma; Metastatic Synovial Sarcoma; Metastatic Undifferentiated Pleomorphic Sarcoma; Unresectable Dedifferentiated Liposarcoma; Unresectable Leiomyosarcoma; Unresectable Myxofibrosarcoma; Unresectable Sarcoma; Unresectable Synovial Sarcoma; Unresectable Undifferentiated Pleomorphic Sarcoma |
National Cancer Institute (NCI) |
2024-02-06 | PHASE1 |
| NCT02877303 | RECRUITING | B Acute Lymphoblastic Leukemia; B Lymphoblastic Lymphoma |
M.D. Anderson Cancer Center |
2016-11-01 | PHASE2 |
| NCT00501826 | RECRUITING | T Acute Lymphoblastic Leukemia; T Lymphoblastic Lymphoma |
M.D. Anderson Cancer Center |
2007-07-11 | PHASE2 |
| NCT06977711 | RECRUITING | Diffuse Large B-cell Lymphoma |
The University of Texas Health Science Center at San Antonio |
2025-06-20 | PHASE1 |
| NCT03117751 | ACTIVE_NOT_RECRUITING | Acute Lymphoblastic Leukemia; Acute Lymphoblastic Lymphoma |
St. Jude Children's Research Hospital |
2017-03-29 | PHASE2; PHASE3 |
| NCT02176967 | ACTIVE_NOT_RECRUITING | Ganglioneuroblastoma; Localized Resectable Neuroblastoma; Localized Unresectable Neuroblastoma; Neuroblastoma |
Children's Oncology Group |
2014-08-08 | PHASE3 |
| NCT06210750 | WITHDRAWN | T Acute Lymphoblastic Leukemia; T Lymphoblastic Lymphoma |
National Cancer Institute (NCI) |
2024-08-09 | PHASE2 |
| NCT02337985 | ACTIVE_NOT_RECRUITING | AIDS-Related Burkitt Lymphoma; AIDS-Related Diffuse Large B-cell Lymphoma; AIDS-Related Plasmablastic Lymphoma; AIDS-Related Primary Effusion Lymphoma; HIV Infection; AIDS Related Non-Hodgkin Lymphoma |
City of Hope Medical Center |
2015-11-20 | PHASE1 |
| NCT02203526 | ACTIVE_NOT_RECRUITING | Primary Central Nervous System Lymphoma |
National Cancer Institute (NCI) |
2014-08-14 | PHASE1 |
| NCT05210374 | RECRUITING | Relapsed Sarcomas |
Case Comprehensive Cancer Center |
2023-03-09 | PHASE1 |
| NCT04776525 | RECRUITING | Soft Tissue Sarcoma |
Oslo University Hospital |
2021-04-27 | PHASE2 |
| NCT05498896 | ACTIVE_NOT_RECRUITING | Triple Negative Breast Cancer |
Queen Mary University of London |
2018-12-19 | PHASE2 |
| NCT07349459 | NOT_YET_RECRUITING | Melatonin; Breast Cancer Patients Diagnosed; Vitamin D Concentration; Doxorubicin |
Tanta University |
2026-04-30 | |
| NCT03587662 | COMPLETED | Metastatic Kidney Medullary Carcinoma; Metastatic Renal Cell Carcinoma; SMARCB1 Negative; Stage III Renal Cell Cancer AJCC v8; Stage IV Renal Cell Cancer AJCC v8 |
M.D. Anderson Cancer Center |
2018-08-17 | PHASE2 |
| NCT03203525 | TERMINATED | Advanced Malignant Neoplasm; Colorectal Carcinoma Metastatic in the Liver; Metastatic Malignant Neoplasm in the Liver; Refractory Malignant Neoplasm |
M.D. Anderson Cancer Center |
2020-06-23 | PHASE1 |
| NCT06820957 | ACTIVE_NOT_RECRUITING | CIC-Rearranged Sarcoma; Metastatic Ewing Sarcoma; Metastatic High Grade Sarcoma; Metastatic Undifferentiated Round Cell Sarcoma; Metastatic Undifferentiated Sarcoma, Not Otherwise Specified; Round Cell Sarcoma With EWSR1-non-ETS Fusion; Sarcoma With BCOR Genetic Alterations |
Children's Oncology Group |
2025-11-10 | PHASE2; PHASE3 |
| NCT05457829 | RECRUITING | Rhabdomyosarcoma, Child |
Sun Yat-sen University |
2023-12-30 | PHASE2 |
| NCT04850495 | ACTIVE_NOT_RECRUITING | Diffuse Large B-Cell Lymphoma; Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma; Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma |
Yazeed Sawalha |
2021-11-16 | PHASE1 |
| NCT06694324 | NOT_YET_RECRUITING | Dedifferentiated Liposarcoma; Soft Tissue Sarcoma (STS) |
Fudan University |
2024-12-01 | PHASE2 |
| NCT05351346 | UNKNOWN | Diffuse Large B Cell Lymphoma |
Ruijin Hospital |
2022-06-01 | PHASE3 |
| NCT05630209 | ACTIVE_NOT_RECRUITING | Brain Tumor |
InSightec |
2023-01-04 | PHASE1; PHASE2 |
| NCT06701344 | NOT_YET_RECRUITING | Enteropathy Associated T Cell Lymphoma |
Ruijin Hospital |
2024-12-04 | PHASE2 |
| NCT05934097 | WITHDRAWN | Diffuse Large B Cell Lymphoma; Transformed Indolent Non-Hodgkin's Lymphoma; Follicular Lymphoma; Mantle Cell Lymphoma; Marginal Zone Lymphoma |
Fate Therapeutics |
2022-12 | PHASE1 |
| NCT05453500 | ACTIVE_NOT_RECRUITING | B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative |
University of Washington |
2023-03-27 | PHASE2 |
| NCT02723994 | COMPLETED | Leukemia |
Incyte Corporation |
2016-09-30 | PHASE2 |
| NCT04872985 | ACTIVE_NOT_RECRUITING | Breast Cancer; Hormone-receptor Positive Breast Cancer |
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University |
2021-04-20 | PHASE2 |
| NCT04092270 | ACTIVE_NOT_RECRUITING | Endometrial High Grade Endometrioid Adenocarcinoma; Fallopian Tube Clear Cell Adenocarcinoma; Fallopian Tube Endometrioid Adenocarcinoma; Fallopian Tube High Grade Serous Adenocarcinoma; Fallopian Tube Malignant Mixed Mesodermal (Mullerian) Tumor; Fallopian Tube Mucinous Adenocarcinoma; Fallopian Tube Transitional Cell Carcinoma; Fallopian Tube Undifferentiated Carcinoma; FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma; FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma; Ovarian High Grade Serous Adenocarcinoma; Ovarian Seromucinous Carcinoma; Ovarian Undifferentiated Carcinoma; Platinum-Sensitive Ovarian Carcinoma; Primary Peritoneal Carcinosarcoma; Primary Peritoneal High Grade Serous Adenocarcinoma; Primary Peritoneal Transitional Cell Carcinoma; Primary Peritoneal Undifferentiated Carcinoma; Recurrent Fallopian Tube Carcinoma; Recurrent Low Grade Fallopian Tube Serous Adenocarcinoma; Recurrent Ovarian Carcinoma; Recurrent Ovarian Clear Cell Adenocarcinoma; Recurrent Ovarian Endometrioid Adenocarcinoma; Recurrent Ovarian Low Grade Serous Adenocarcinoma; Recurrent Ovarian Malignant Mixed Mesodermal (Mullerian) Tumor; Recurrent Ovarian Mucinous Adenocarcinoma; Recurrent Ovarian Transitional Cell Carcinoma; Recurrent Primary Peritoneal Carcinoma; Recurrent Primary Peritoneal Low Grade Serous Adenocarcinoma |
National Cancer Institute (NCI) |
2020-05-07 | PHASE1 |
| NCT03749018 | ACTIVE_NOT_RECRUITING | Aggressive Non-Hodgkin Lymphoma; Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Ann Arbor Stage II B-Cell Non-Hodgkin Lymphoma; Ann Arbor Stage II Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Ann Arbor Stage III B-Cell Non-Hodgkin Lymphoma; Ann Arbor Stage III Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Ann Arbor Stage IV B-Cell Non-Hodgkin Lymphoma; Ann Arbor Stage IV Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Diffuse Large B-Cell Lymphoma; High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements; High Grade B-Cell Lymphoma, Not Otherwise Specified; Indolent Non-Hodgkin Lymphoma; Mediastinal B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma; Transformed Non-Hodgkin Lymphoma |
David Bond, MD |
2019-01-02 | PHASE2 |
| NCT06277154 | RECRUITING | Leiomyosarcoma; Liposarcoma; Synovial Sarcoma; Angiosarcoma; Undifferentiated Pleomorphic Sarcoma; Epithelioid Sarcoma; Malignant Peripheral Nerve Sheath Tumors; Fibrosarcoma; Pleomorphic Rhabdomyosarcoma; Endometrial Stromal Sarcoma; Desmoplastic Small Round Cell Tumor |
HRYZ Biotech Co. |
2024-02-21 | PHASE2 |
| NCT04650984 | UNKNOWN | Soft Tissue Sarcoma |
Philogen S.p.A. |
2017-11-29 | PHASE3 |
| NCT03269669 | ACTIVE_NOT_RECRUITING | Grade 1 Follicular Lymphoma; Grade 2 Follicular Lymphoma; Grade 3a Follicular Lymphoma; Recurrent Follicular Lymphoma; Refractory Follicular Lymphoma |
National Cancer Institute (NCI) |
2018-01-23 | PHASE2 |
| NCT03719430 | COMPLETED | Soft Tissue Sarcoma |
Alexander Z. Wei, MD |
2019-03-20 | PHASE2 |
| NCT02710734 | COMPLETED | Urothelial Carcinoma of the Bladder |
Fox Chase Cancer Center |
2016-02-24 | PHASE2 |
| NCT05824975 | RECRUITING | Advanced Solid Tumor; Metastatic Solid Tumor; Soft Tissue Sarcoma (STS); Platinum-resistant Ovarian Cancer (PROC); Hepatocellular Carcinoma (HCC); Colorectal Cancer (CRC); HER2 Negative Breast Cancer; Cutaneous Melanoma; Renal Cell Carcinoma (RCC) |
GI Innovation, Inc. |
2023-05-30 | PHASE1; PHASE2 |
| NCT06404463 | NOT_YET_RECRUITING | Early Breast Cancer; Neoadjuvant Therapy; HR+HER2- Breast Cancer |
Fudan University |
2024-05-06 | PHASE2 |
| NCT03036488 | COMPLETED | Triple Negative Breast Neoplasms |
Merck Sharp & Dohme LLC |
2017-03-07 | PHASE3 |
| NCT04835870 | UNKNOWN | Non-GCB/ABC Diffuse Large B-Cell Lymphoma |
The First Affiliated Hospital of Soochow University |
2021-04-01 | PHASE2 |
| NCT03340376 | UNKNOWN | Cervical Cancer |
Universitaire Ziekenhuizen KU Leuven |
2017-08-30 | PHASE2 |
| NCT04626791 | ACTIVE_NOT_RECRUITING | Mantle Cell Lymphoma |
Academic and Community Cancer Research United |
2021-08-03 | PHASE2 |
| NCT05422066 | UNKNOWN | DLBCL Germinal Center B-Cell Type |
Li Zhiming |
2022-07-26 | PHASE2 |
| NCT03233347 | ACTIVE_NOT_RECRUITING | Ann Arbor Stage I Hodgkin Lymphoma; Ann Arbor Stage IA Hodgkin Lymphoma; Ann Arbor Stage IB Hodgkin Lymphoma; Ann Arbor Stage II Hodgkin Lymphoma; Ann Arbor Stage IIA Hodgkin Lymphoma; Ann Arbor Stage IIB Hodgkin Lymphoma; Classic Hodgkin Lymphoma |
Academic and Community Cancer Research United |
2017-10-13 | PHASE2 |
| NCT04757337 | UNKNOWN | Advanced Soft-tissue Sarcoma; Metastatic Soft-tissue Sarcoma |
UNICANCER |
2021-06-18 | PHASE3 |
| NCT05051891 | COMPLETED | Treatment-naїve Mantle Cell Lymphoma |
Beijing InnoCare Pharma Tech Co., Ltd. |
2021-12-22 | PHASE3 |
| NCT03983226 | RECRUITING | Ovarian Cancer Recurrent; Fallopian Tube Cancer; Primary Peritoneal Carcinoma |
Shanghai Gynecologic Oncology Group |
2019-10-18 | PHASE2 |
| NCT05518383 | RECRUITING | Non-hodgkin Lymphoma,B Cell; Burkitt Lymphoma; Primary Mediastinal Lymphoma; Primary CNS Lymphoma; Diffuse Large B-cell Lymphoma |
Federal Research Institute of Pediatric Hematology, Oncology and Immunology |
2022-05-25 | PHASE4 |
| NCT06545656 | COMPLETED | Sexually Transmitted Infection |
Emory University |
2024-09-13 | PHASE4 |
| NCT06703593 | COMPLETED | Breast Cancer Female |
British University In Egypt |
2023-10-01 | PHASE2 |
| NCT05201248 | ACTIVE_NOT_RECRUITING | B-Cell Non-Hodgkin Lymphoma |
Genmab |
2022-03-10 | PHASE1; PHASE2 |
| NCT05238064 | UNKNOWN | PI3Kδ Inhibitor; Parsaclisib; CHOP; PTCL |
Fudan University |
2022-03 | PHASE1; PHASE2 |
| NCT02853500 | WITHDRAWN | Liver Cancer |
Dana-Farber Cancer Institute |
2016-07 | PHASE4 |
| NCT07171827 | COMPLETED | Anti-CD30; Brentuximab; Doxorubicin; Vinblastine; Dacarbazine; Frontline; Advanced Classical Hodgkin Lymphoma |
Helwan University |
2023-03-01 | |
| NCT05858710 | COMPLETED | Sarcoma, Soft Tissue |
Thermosome GmbH |
2023-04-19 | PHASE1 |
| NCT04679064 | UNKNOWN | Ovarian Cancer |
Fondazione Policlinico Universitario Agostino Gemelli IRCCS |
2020-12-01 | PHASE3 |
| NCT04432714 | RECRUITING | DLBCL; Untreated; MYC Gene Rearrangement |
The First Affiliated Hospital with Nanjing Medical University |
2020-06-09 | PHASE1; PHASE2 |
| NCT07668076 | COMPLETED | Breast Cancer; Doxorubicin Induced Cardiomyopathy |
Damanhour University |
2022-11-15 | PHASE2 |
| NCT03220022 | ACTIVE_NOT_RECRUITING | AIDS-Related Lymphoma; Ann Arbor Stage II Diffuse Large B-Cell Lymphoma; Ann Arbor Stage III Diffuse Large B-Cell Lymphoma; Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma |
National Cancer Institute (NCI) |
2018-03-16 | PHASE1 |
| NCT02584478 | UNKNOWN | Endometrial Carcinoma; Ovarian Carcinoma; Fallopian Tube Carcinoma; Primary Peritoneal Carcinoma; Cervical Carcinoma |
Advenchen Laboratories, LLC |
2015-12 | PHASE3 |
| NCT05747521 | UNKNOWN | Soft Tissue Sarcoma |
Henan Cancer Hospital |
2021-04-29 | |
| NCT04980222 | ACTIVE_NOT_RECRUITING | Lymphoma |
Hoffmann-La Roche |
2022-03-22 | PHASE2 |
| NCT03598270 | COMPLETED | Recurrent Ovarian Carcinoma |
Grupo Español de Investigación en Cáncer de Ovario |
2018-11-21 | PHASE3 |
| NCT00878254 | COMPLETED | Mantle-Cell Lymphoma |
University of Miami |
2009-03-25 | PHASE2 |
| NCT05613088 | COMPLETED | Neoplasms, Ovarian |
Bristol-Myers Squibb |
2023-02-01 | PHASE2 |
| NCT04383743 | COMPLETED | Stage II Bladder Cancer AJCC v8; Stage IIIA Bladder Cancer AJCC v8; Muscle Invasive Bladder Carcinoma |
University of Washington |
2020-11-24 | PHASE2 |
| NCT04204941 | TERMINATED | Advanced Soft-tissue Sarcoma; Advanced Epithelioid Sarcoma |
Epizyme, Inc. |
2019-12-19 | PHASE1 |
| NCT04656262 | TERMINATED | Soft Tissue Sarcoma Adult |
Istituto Oncologico Veneto IRCCS |
2018-09-10 | PHASE3 |
| NCT05872412 | UNKNOWN | Triple Negative Breast Cancer |
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh |
2023-06-01 | PHASE2 |
| NCT03794778 | UNKNOWN | Efficacy and Safety |
Women's Hospital School Of Medicine Zhejiang University |
2019-03-19 | PHASE4 |
| NCT03505762 | ACTIVE_NOT_RECRUITING | B-Cell Non-Hodgkin Lymphoma |
Wake Forest University Health Sciences |
2018-07-19 | PHASE2 |
| NCT03793361 | COMPLETED | Metastatic Soft Tissue Sarcoma |
Centre Oscar Lambret |
2019-05-15 | PHASE2 |
| NCT04974996 | WITHDRAWN | Diffuse Large B-Cell Lymphoma |
ADC Therapeutics S.A. |
2022-02-01 | PHASE1 |
| NCT04213794 | TERMINATED | Malignant Abdominal Neoplasm; Malignant Pelvic Neoplasm; Recurrent Colon Carcinoma; Recurrent Desmoplastic Small Round Cell Tumor; Recurrent Fallopian Tube Carcinoma; Recurrent Gastric Carcinoma; Recurrent Liposarcoma; Recurrent Malignant Mesothelioma; Recurrent Ovarian Carcinoma; Recurrent Primary Peritoneal Carcinoma; Recurrent Rectal Carcinoma; Recurrent Rhabdomyosarcoma; Recurrent Sarcoma; Refractory Colon Carcinoma; Refractory Desmoplastic Small Round Cell Tumor; Refractory Fallopian Tube Carcinoma; Refractory Gastric Carcinoma; Refractory Liposarcoma; Refractory Malignant Mesothelioma; Refractory Ovarian Carcinoma; Refractory Primary Peritoneal Carcinoma; Refractory Rectal Carcinoma; Refractory Rhabdomyosarcoma; Refractory Sarcoma; Resectable Liposarcoma; Resectable Malignant Mesothelioma; Resectable Sarcoma |
Mayo Clinic |
2019-11-08 | EARLY_PHASE1 |
| NCT00390793 | COMPLETED | Acute Lymphoblastic Leukemia; BCR-ABL1 Fusion Protein Expression; Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Philadelphia Chromosome Positive; Recurrent Acute Lymphoblastic Leukemia; t(9;22) |
M.D. Anderson Cancer Center |
2006-09-28 | PHASE2 |
| NCT05481645 | TERMINATED | Advanced Endometrial Cancer; Sarcoma of Uterus |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
2022-08-26 | PHASE2 |
| NCT04922567 | RECRUITING | Peripheral T-Cell Lymphoma; Lenalidomide; CHOP |
Second Affiliated Hospital, Zhejiang University, School of Medicine |
2021-04-01 | PHASE2 |
| NCT04928222 | ACTIVE_NOT_RECRUITING | Basal Cell Carcinoma |
SkinJect, Inc. |
2021-09-24 | PHASE1; PHASE2 |
| NCT03331341 | COMPLETED | Classical Hodgkin Lymphoma |
University of Washington |
2019-01-09 | PHASE1; PHASE2 |
| NCT00657878 | UNKNOWN | Ovarian Cancer |
National Cancer Institute, Naples |
2008-11 | PHASE3 |
| NCT06186700 | Active not recruiting | Breast Cancer Female |
Mansoura University |
2023-12-25 | Phase 2 |
| NCT05138146 | UNKNOWN | Sarcoma, Soft Tissue |
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. |
2021-12-30 | PHASE2 |
| NCT05567601 | Not yet recruiting | Ovarian Cancer|AIDS-related Kaposi Sarcoma|Multiple Myeloma|Metastatic Breast Cancer |
Baxter Healthcare Corporation |
2023-11-30 | Phase 1 |
| NCT05536102 | RECRUITING | Gastric Cancer |
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine |
2022-09-05 | PHASE2 |
| NCT04172259 | ACTIVE_NOT_RECRUITING | Breast Cancer; Neoadjuvant Chemotherapy |
Sun Yat-sen University |
2019-01-10 | PHASE2 |
| NCT02626455 | TERMINATED | Lymphoma, Non-Hodgkin |
Bayer |
2016-01-06 | PHASE3 |
| NCT06088290 | Recruiting | Leiomyosarcoma |
PharmaMar |
2023-09-21 | Phase 2|Phase 3 |
| NCT02348216 | COMPLETED | Refractory Diffuse Large B Cell Lymphoma (DLBCL); Relapsed Diffuse Large B-Cell Lymphoma; Transformed Follicular Lymphoma (TFL); Primary Mediastinal B-cell Lymphoma (PMBCL); High Grade B-cell Lymphoma (HGBCL) |
Kite, A Gilead Company |
2015-04-21 | PHASE1; PHASE2 |
| NCT03864419 | TERMINATED | Burkitt Lymphoma; KSHV-associated Multicentric Castleman Disease; Diffuse Large B-Cell Lymphoma |
Fred Hutchinson Cancer Center |
2019-10-24 | PHASE1 |
| NCT05748834 | Recruiting | Breast Cancer |
SCRI Development Innovations LLC|Seagen Inc. |
2023-07-24 | Phase 2 |
| NCT07648940 | COMPLETED | Advanced Ovarian Cancer; Metastatic Breast Cancer |
Zodiac Produtos Farmaceuticos S.A. |
2023-02-13 | PHASE1 |
| NCT02839707 | ACTIVE_NOT_RECRUITING | Fallopian Tube High Grade Serous Adenocarcinoma; Ovarian High Grade Serous Adenocarcinoma; Ovarian Seromucinous Carcinoma; Primary Peritoneal High Grade Serous Adenocarcinoma; Recurrent Fallopian Tube Carcinoma; Recurrent Fallopian Tube Clear Cell Adenocarcinoma; Recurrent Fallopian Tube Endometrioid Adenocarcinoma; Recurrent Fallopian Tube Undifferentiated Carcinoma; Recurrent Ovarian Carcinoma; Recurrent Ovarian Clear Cell Adenocarcinoma; Recurrent Ovarian Endometrioid Adenocarcinoma; Recurrent Ovarian Undifferentiated Carcinoma; Recurrent Platinum-Resistant Fallopian Tube Carcinoma; Recurrent Platinum-Resistant Ovarian Carcinoma; Recurrent Platinum-Resistant Primary Peritoneal Carcinoma; Recurrent Primary Peritoneal Carcinoma; Recurrent Primary Peritoneal Clear Cell Adenocarcinoma; Recurrent Primary Peritoneal Endometrioid Adenocarcinoma; Recurrent Primary Peritoneal Undifferentiated Carcinoma |
National Cancer Institute (NCI) |
2017-06-23 | PHASE2; PHASE3 |
| NCT05853120 | Recruiting | Sexually Transmitted Diseases |
Emory University|Centers for Disease Control and Prevention |
2023-05-31 | Phase 4 |
| NCT04038489 | WITHDRAWN | Breast Cancer; Estrogen Receptor-positive Breast Cancer |
University of Virginia |
2019-10-18 | PHASE2 |
| NCT02312245 | COMPLETED | Recurrent Fallopian Tube Carcinoma; Recurrent Ovarian Carcinoma; Recurrent Primary Peritoneal Carcinoma |
Mayo Clinic |
2015-07-21 | PHASE2 |
| NCT04480099 | UNKNOWN | Peripheral T-cell Lymphoma |
Ruijin Hospital |
2020-07-29 | PHASE2 |
| NCT04852367 | WITHDRAWN | Pancreatic Ductal Adenocarcinoma; Pancreatic Cancer Stage IV; Pancreatic Cancer Non-resectable; Pancreatic Cancer Metastatic |
University of Oxford |
2021-06-16 | PHASE1 |
| NCT02372409 | TERMINATED | Glioma; Pilocytic Astrocytoma; Anaplastic Astrocytoma; Glioblastoma; Mixed Oligoastrocytoma; Mixed Glioma; Oligodendroglioma; Optic Glioma; Astrocytoma |
Washington University School of Medicine |
2015-08-14 | PHASE2 |
| NCT00003927 | COMPLETED | Breast Cancer |
City of Hope Medical Center |
1999-05-18 | PHASE1 |
| NCT05295589 | WITHDRAWN | Platinum-Refractory Fallopian Tube Carcinoma; Platinum-Refractory Ovarian Carcinoma; Platinum-Refractory Primary Peritoneal Carcinoma; Recurrent Fallopian Tube Endometrioid Adenocarcinoma; Recurrent Fallopian Tube High Grade Serous Adenocarcinoma; Recurrent Ovarian Endometrioid Adenocarcinoma; Recurrent Ovarian High Grade Serous Adenocarcinoma; Recurrent Platinum-Resistant Fallopian Tube Carcinoma; Recurrent Platinum-Resistant Ovarian Carcinoma; Recurrent Platinum-Resistant Primary Peritoneal Carcinoma; Recurrent Primary Peritoneal Endometrioid Adenocarcinoma; Recurrent Primary Peritoneal High Grade Serous Adenocarcinoma |
National Cancer Institute (NCI) |
2022-06-30 | PHASE2 |
| NCT04584112 | COMPLETED | Triple-Negative Breast Cancer |
Hoffmann-La Roche |
2020-09-28 | PHASE1 |
| NCT04209855 | COMPLETED | Epithelial Ovarian Cancer; Peritoneal Cancer; Fallopian Tube Cancer |
AbbVie |
2019-12-31 | PHASE3 |
| NCT04842318 | UNKNOWN | Follicular Lymphoma |
Ruijin Hospital |
2021-03-01 | PHASE4 |
| NCT06098599 | COMPLETED | Advanced Breast Cancer |
Luye Pharma Group Ltd. |
2022-05-17 | PHASE1 |
| NCT04753177 | UNKNOWN | The Neoadjuvant Therapy |
Saint Petersburg State Budgetary Healthcare Institution, City Clinical Oncology Dispensary |
2021-01-28 | PHASE2; PHASE3 |
| NCT04739800 | ACTIVE_NOT_RECRUITING | Fallopian Tube Mucinous Adenocarcinoma; Ovarian Seromucinous Carcinoma; Platinum-Refractory Fallopian Tube Carcinoma; Platinum-Refractory Ovarian Carcinoma; Platinum-Refractory Primary Peritoneal Carcinoma; Recurrent Fallopian Tube Clear Cell Adenocarcinoma; Recurrent Fallopian Tube Endometrioid Adenocarcinoma; Recurrent Fallopian Tube High Grade Serous Adenocarcinoma; Recurrent Fallopian Tube Mucinous Adenocarcinoma; Recurrent Fallopian Tube Transitional Cell Carcinoma; Recurrent Fallopian Tube Undifferentiated Carcinoma; Recurrent Low Grade Fallopian Tube Serous Adenocarcinoma; Recurrent Ovarian Clear Cell Adenocarcinoma; Recurrent Ovarian Endometrioid Adenocarcinoma; Recurrent Ovarian High Grade Serous Adenocarcinoma; Recurrent Ovarian Low Grade Serous Adenocarcinoma; Recurrent Ovarian Mucinous Adenocarcinoma; Recurrent Ovarian Seromucinous Carcinoma; Recurrent Ovarian Transitional Cell Carcinoma; Recurrent Ovarian Undifferentiated Carcinoma; Recurrent Platinum-Resistant Fallopian Tube Carcinoma; Recurrent Platinum-Resistant Ovarian Carcinoma; Recurrent Platinum-Resistant Primary Peritoneal Carcinoma; Recurrent Primary Peritoneal Clear Cell Adenocarcinoma; Recurrent Primary Peritoneal Endometrioid Adenocarcinoma; Recurrent Primary Peritoneal High Grade Serous Adenocarcinoma; Recurrent Primary Peritoneal Low Grade Serous Adenocarcinoma; Recurrent Primary Peritoneal Transitional Cell Carcinoma; Recurrent Primary Peritoneal Undifferentiated Carcinoma; Refractory Fallopian Tube Clear Cell Adenocarcinoma; Refractory Fallopian Tube Endometrioid Adenocarcinoma; Refractory Fallopian Tube High Grade Serous Adenocarcinoma; Refractory Fallopian Tube Mucinous Adenocarcinoma; Refractory Fallopian Tube Transitional Cell Carcinoma; Refractory Fallopian Tube Undifferentiated Carcinoma; Refractory Low Grade Fallopian Tube Serous Adenocarcinoma; Refractory Ovarian Clear Cell Adenocarcinoma; Refractory Ovarian Endometrioid Adenocarcinoma; Refractory Ovarian High Grade Serous Adenocarcinoma; Refractory Ovarian Low Grade Serous Adenocarcinoma; Refractory Ovarian Mucinous Adenocarcinoma; Refractory Ovarian Seromucinous Carcinoma; Refractory Ovarian Transitional Cell Carcinoma; Refractory Ovarian Undifferentiated Carcinoma; Refractory Primary Peritoneal Clear Cell Adenocarcinoma; Refractory Primary Peritoneal Endometrioid Adenocarcinoma; Refractory Primary Peritoneal High Grade Serous Adenocarcinoma; Refractory Primary Peritoneal Low Grade Serous Adenocarcinoma; Refractory Primary Peritoneal Transitional Cell Carcinoma; Refractory Primary Peritoneal Undifferentiated Carcinoma |
National Cancer Institute (NCI) |
2021-06-10 | PHASE2 |
| NCT01990352 | TERMINATED | Breast Cancer |
University of Arizona |
2013-11-05 | PHASE2 |
| NCT03071926 | UNKNOWN | Advanced Breast Cancer |
Fudan University |
2017-03-01 | PHASE2 |
| NCT02661503 | UNKNOWN | Classical Hodgkin Lymphoma |
University of Cologne |
2016-07 | PHASE3 |
| NCT03749850 | UNKNOWN | Metastatic Breast Cancer; Breast Cancer; Breast Neoplasms; Stage IV Breast Cancer; Metastatic Cancer; Invasive Ductal Carcinoma of Female Breast; Invasive Ductal Breast Cancer; Adenocarcinoma Breast |
UMC Utrecht |
2021-03 | PHASE1 |
| NCT02636322 | COMPLETED | Diffuse Large B-Cell Lymphoma Unclassifiable |
M.D. Anderson Cancer Center |
2016-03-29 | PHASE2 |
| NCT02584309 | COMPLETED | Sarcoma, Soft Tissue; Soft Tissue Sarcoma; Undifferentiated Pleomorphic Sarcoma; Leiomyosarcoma; Liposarcoma; Synovial Sarcoma; Myxofibrosarcoma; Angiosarcoma; Fibrosarcoma; Malignant Peripheral Nerve Sheath Tumor; Epithelioid Sarcoma |
Washington University School of Medicine |
2016-02-22 | PHASE2 |
| NCT04358341 | UNKNOWN | Gastric Cancer |
Sixth Affiliated Hospital, Sun Yat-sen University |
2020-06-17 | PHASE2 |
| NCT03808480 | UNKNOWN | Non-small Cell Lung Cancer |
National Cancer Center, Korea |
2019-01-23 | PHASE2 |
| NCT01974440 | COMPLETED | Lymphoma |
Janssen Research & Development, LLC |
2014-01-31 | PHASE3 |
| NCT04081389 | COMPLETED | Anatomic Stage 0 Breast Cancer AJCC v8; Anatomic Stage I Breast Cancer AJCC v8; Anatomic Stage IA Breast Cancer AJCC v8; Anatomic Stage IB Breast Cancer AJCC v8; Anatomic Stage II Breast Cancer AJCC v8; Anatomic Stage IIA Breast Cancer AJCC v8; Anatomic Stage IIB Breast Cancer AJCC v8; Early-Stage Breast Carcinoma; Estrogen Receptor Negative; HER2/Neu Negative; Progesterone Receptor Negative; Prognostic Stage 0 Breast Cancer AJCC v8; Prognostic Stage I Breast Cancer AJCC v8; Prognostic Stage IA Breast Cancer AJCC v8; Prognostic Stage IB Breast Cancer AJCC v8; Prognostic Stage II Breast Cancer AJCC v8; Prognostic Stage IIA Breast Cancer AJCC v8; Prognostic Stage IIB Breast Cancer AJCC v8; Triple-Negative Breast Carcinoma |
Roswell Park Cancer Institute |
2019-12-06 | PHASE1 |
| NCT04660799 | COMPLETED | Lymphoma, Large B-Cell, Diffuse |
Hoffmann-La Roche |
2021-02-24 | PHASE2 |
| NCT01750073 | COMPLETED | Estrogen Receptor Negative; Estrogen Receptor Positive; HER2/Neu Negative; HER2/Neu Positive; Invasive Breast Carcinoma; Progesterone Receptor Negative; Progesterone Receptor Positive; Stage IA Breast Cancer; Stage II Breast Cancer; Stage IIA Breast Cancer; Stage IIB Breast Cancer; Stage III Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer; Triple-Negative Breast Carcinoma |
University of Nebraska |
2012-12-07 | PHASE2 |
| NCT03539328 | UNKNOWN | Ovarian Cancer |
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano |
2018-06 | PHASE2 |
| NCT04356872 | UNKNOWN | Sarcoma, Soft Tissue |
Fudan University |
2020-04-08 | PHASE2 |
| NCT03517449 | COMPLETED | Endometrial Neoplasms |
Eisai Inc. |
2018-06-11 | PHASE3 |
| NCT03792867 | UNKNOWN | Retroperitoneal Sarcoma |
National Cancer Centre, Singapore |
2018-07-23 | |
| NCT02166463 | ACTIVE_NOT_RECRUITING | Ann Arbor Stage IIB Hodgkin Lymphoma; Ann Arbor Stage IIIB Hodgkin Lymphoma; Ann Arbor Stage IVA Hodgkin Lymphoma; Ann Arbor Stage IVB Hodgkin Lymphoma; Childhood Hodgkin Lymphoma; Classic Hodgkin Lymphoma |
National Cancer Institute (NCI) |
2015-03-19 | PHASE3 |
| NCT04024462 | COMPLETED | HER2-positive Early Breast Cancer |
Hoffmann-La Roche |
2020-02-05 | PHASE3 |
| NCT03335241 | UNKNOWN | Ovarian Cancer |
Sun Yat-sen University |
2017-03-01 | PHASE2 |
| NCT01882816 | COMPLETED | Thyroid Cancer |
Memorial Sloan Kettering Cancer Center |
2013-06-13 | PHASE2 |
| NCT02577783 | UNKNOWN | Multiple Myeloma |
The First Affiliated Hospital of Soochow University |
2015-10 | PHASE4 |
| NCT00740805 | ACTIVE_NOT_RECRUITING | Ann Arbor Stage III Non-Hodgkin Lymphoma; Ann Arbor Stage IV Non-Hodgkin Lymphoma; Solid Neoplasm |
National Cancer Institute (NCI) |
2008-08-18 | PHASE1 |
| NCT01779050 | TERMINATED | Breast Neoplasms |
Washington University School of Medicine |
2013-12-19 | PHASE2 |
| NCT02918747 | UNKNOWN | Lymphoma |
Hunan Cancer Hospital |
2016-09 | PHASE2 |
| NCT02766699 | COMPLETED | Glioblastoma; Astrocytoma, Grade IV |
Engeneic Pty Limited |
2016-10-25 | PHASE1 |
| NCT02073097 | COMPLETED | Contiguous Stage II Adult Diffuse Large Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Stage I Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma |
Case Comprehensive Cancer Center |
2015-01-28 | PHASE1; PHASE2 |
| NCT02822157 | UNKNOWN | Ovarian Epithelial Cancer |
Universitaire Ziekenhuizen KU Leuven |
2016-08 | PHASE2 |
| NCT00670358 | COMPLETED | Lymphoma |
Mayo Clinic |
2008-08-25 | PHASE1; PHASE2 |
| NCT03591276 | RECRUITING | Metastatic Breast Cancer |
Shaare Zedek Medical Center |
2019-04-18 | PHASE1; PHASE2 |
| NCT03880695 | UNKNOWN | Sarcoma |
Peking University People's Hospital |
2019-03 | PHASE2 |
| NCT01979536 | COMPLETED | Anaplastic Large Cell Lymphoma, ALK-Positive; Ann Arbor Stage II Noncutaneous Childhood Anaplastic Large Cell Lymphoma; Ann Arbor Stage III Noncutaneous Childhood Anaplastic Large Cell Lymphoma; Ann Arbor Stage IV Noncutaneous Childhood Anaplastic Large Cell Lymphoma |
National Cancer Institute (NCI) |
2013-11-13 | PHASE2 |
| NCT03596281 | COMPLETED | Ovarian Cancer |
Gustave Roussy, Cancer Campus, Grand Paris |
2018-12-05 | PHASE1 |
| NCT04231929 | WITHDRAWN | Hepatocellular Carcinoma |
Terumo Europe N.V. |
2020-05 | |
| NCT01004978 | COMPLETED | Hepatocellular Carcinoma; Unresectable Hepatocellular Carcinoma |
National Cancer Institute (NCI) |
2009-10-28 | PHASE3 |
| NCT02315196 | ACTIVE_NOT_RECRUITING | Estrogen Receptor-negative Breast Cancer; HER2-negative Breast Cancer; Progesterone Receptor-negative Breast Cancer; Stage IIA Breast Cancer; Stage IIB Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer; Triple-negative Breast Cancer |
Rutgers, The State University of New Jersey |
2015-02-25 | PHASE2 |
| NCT03892330 | NOT_YET_RECRUITING | 0.5-14 Year Old Children With Nephroblastoma |
Shengjing Hospital |
2019-06-01 | PHASE4 |
| NCT01319981 | COMPLETED | Leukemia |
M.D. Anderson Cancer Center |
2013-03-05 | PHASE2 |
| NCT03603379 | COMPLETED | Glioblastoma |
University Hospital, Basel, Switzerland |
2018-11-16 | PHASE1 |
| NCT03908528 | COMPLETED | Breast Cancer; Chemotherapeutic Toxicity |
Damanhour University |
2019-03-01 | |
| NCT03452553 | WITHDRAWN | Hepatocellular Carcinoma (HCC) |
Boston Scientific Corporation |
2018-07-01 | |
| NCT03617432 | UNKNOWN | Experimental Tumor |
Peking University |
2018-08-28 | PHASE2 |
| NCT03294577 | UNKNOWN | Chemotherapy-induced Neutropenia |
BeyondSpring Pharmaceuticals Inc. |
2019-10-23 | PHASE3 |
| NCT03002805 | UNKNOWN | Sarcoma |
CBA Research |
2018-03-29 | PHASE1 |
| NCT04213612 | UNKNOWN | Unrecognized Condition |
Sun Yat-sen University |
2019-12-30 | PHASE1 |
| NCT03108300 | UNKNOWN | Malignant Soft Tissue Sarcoma |
Ain Shams University |
2019-08-30 | PHASE2 |
| NCT02506777 | UNKNOWN | Breast Cancer |
N.N. Petrov National Medical Research Center of Oncology |
2015-07 | PHASE2 |
| NCT02538926 | WITHDRAWN | B Acute Lymphoblastic Leukemia; B Lymphoblastic Lymphoma; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent B Lymphoblastic Lymphoma; Recurrent T Lymphoblastic Leukemia/Lymphoma; Refractory B Lymphoblastic Lymphoma; Refractory T Lymphoblastic Lymphoma; T Acute Lymphoblastic Leukemia; T Lymphoblastic Lymphoma |
University of Washington |
2018-07-01 | PHASE2 |
| NCT01359592 | COMPLETED | Lymphoma |
SWOG Cancer Research Network |
2011-09 | PHASE2 |
| NCT02790580 | UNKNOWN | Breast Cancer |
National University Hospital, Singapore |
2016-05 | PHASE2 |
| NCT03276013 | COMPLETED | Endometrial Neoplasms |
Vall d'Hebron Institute of Oncology |
2018-05-30 | PHASE2 |
| NCT01363128 | COMPLETED | Acute Lymphoblastic Leukemia; Adult Acute Lymphoblastic Leukemia in Complete Remission; Burkitt Leukemia; Burkitt Lymphoma; CD20 Positive; Childhood Acute Lymphoblastic Leukemia in Complete Remission; Lymphoblastic Lymphoma |
M.D. Anderson Cancer Center |
2011-07-12 | PHASE2 |
| NCT01856192 | ACTIVE_NOT_RECRUITING | Ann Arbor Stage II Diffuse Large B-Cell Lymphoma; Ann Arbor Stage III Diffuse Large B-Cell Lymphoma; Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma |
National Cancer Institute (NCI) |
2013-08-27 | PHASE2 |
| NCT02888665 | COMPLETED | Sarcoma |
Fred Hutchinson Cancer Center |
2016-12-05 | PHASE1; PHASE2 |
| NCT02446600 | ACTIVE_NOT_RECRUITING | Fallopian Tube Clear Cell Adenocarcinoma; Fallopian Tube Transitional Cell Carcinoma; Fallopian Tube Undifferentiated Carcinoma; Ovarian Clear Cell Adenocarcinoma; Ovarian Endometrioid Tumor; Ovarian Seromucinous Carcinoma; Ovarian Serous Tumor; Ovarian Transitional Cell Carcinoma; Ovarian Undifferentiated Carcinoma; Recurrent Fallopian Tube Carcinoma; Recurrent Ovarian Carcinoma; Recurrent Ovarian Endometrioid Adenocarcinoma; Recurrent Primary Peritoneal Carcinoma |
National Cancer Institute (NCI) |
2016-03-28 | PHASE3 |
| NCT02758366 | TERMINATED | Glioblastoma (GBM); DIPG; Brainstem Glioma, Pediatric; Diffuse Spinal Glioma; Bilateral Thalamic Glioma; Gliomatosis Cerebri; Anaplastic Astrocytoma; Midline Diffuse Glioma |
Meyer Children's Hospital IRCCS |
2016-02 | PHASE2 |
| NCT03563144 | WITHDRAWN | Metastatic Pancreatic Cancer |
ImmunityBio, Inc. |
2018-08 | PHASE2 |
| NCT04460820 | COMPLETED | Bioequivalence |
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. |
2019-07-04 | |
| NCT02978495 | COMPLETED | BRCA1 Hereditary Breast and Ovarian Cancer Syndrome |
Barretos Cancer Hospital |
2017-05-17 | PHASE2 |
| NCT01228331 | COMPLETED | Leukemia |
Universitätsklinikum Hamburg-Eppendorf |
2010-10 | PHASE2; PHASE3 |
| NCT02858804 | COMPLETED | Mantle Cell Lymphoma |
Institute of Hematology & Blood Diseases Hospital, China |
2016-01 | PHASE4 |
| NCT00058422 | COMPLETED | Lymphoma |
Memorial Sloan Kettering Cancer Center |
2003-02-10 | PHASE2 |
| NCT02561273 | COMPLETED | Anaplastic Large Cell Lymphoma, ALK-Negative; Anaplastic Large Cell Lymphoma, ALK-Positive; Hepatosplenic T-Cell Lymphoma; Peripheral T-Cell Lymphoma, Not Otherwise Specified; Stage II Angioimmunoblastic T-cell Lymphoma; Stage II Enteropathy-Associated T-Cell Lymphoma; Stage III Angioimmunoblastic T-cell Lymphoma; Stage III Enteropathy-Associated T-Cell Lymphoma; Stage IV Angioimmunoblastic T-cell Lymphoma; Stage IV Enteropathy-Associated T-Cell Lymphoma |
University of Nebraska |
2015-09-28 | PHASE1; PHASE2 |
| NCT03949634 | UNKNOWN | Early Breast Cancer |
Fudan University |
2017-09-01 | PHASE3 |
| NCT03009201 | COMPLETED | Advanced Soft Tissue Sarcoma; Locally Advanced Angiosarcoma; Locally Advanced Leiomyosarcoma; Locally Advanced Liposarcoma; Locally Advanced Malignant Peripheral Nerve Sheath Tumor; Locally Advanced Myxofibrosarcoma; Locally Advanced Undifferentiated Pleomorphic Sarcoma; Metastatic Angiosarcoma; Metastatic Epithelioid Sarcoma; Metastatic Fibrosarcoma; Metastatic Liposarcoma; Metastatic Malignant Peripheral Nerve Sheath Tumor; Metastatic Myxofibrosarcoma; Metastatic Soft Tissue Sarcoma; Metastatic Synovial Sarcoma; Metastatic Undifferentiated Pleomorphic Sarcoma; Myxofibrosarcoma; Pleomorphic Rhabdomyosarcoma; Stage III Soft Tissue Sarcoma AJCC v7; Stage IV Soft Tissue Sarcoma AJCC v7; Undifferentiated (Embryonal) Sarcoma; Unresectable Leiomyosarcoma; Unresectable Liposarcoma; Unresectable Malignant Peripheral Nerve Sheath Tumor; Unresectable Soft Tissue Sarcoma; Unresectable Synovial Sarcoma; Unresectable Undifferentiated Pleomorphic Sarcoma |
OHSU Knight Cancer Institute |
2017-03-10 | PHASE1 |
| NCT02449278 | UNKNOWN | Diffuse Large B-cell Lymphoma |
Wuhan University |
2015-10 | PHASE3 |
| NCT02751918 | COMPLETED | Ovarian Neoplasms |
Bayer |
2016-06-08 | PHASE1 |
| NCT03493854 | COMPLETED | Early Breast Cancer |
Hoffmann-La Roche |
2018-06-14 | PHASE3 |
| NCT02180867 | COMPLETED | Alveolar Soft Part Sarcoma; Angiomatoid Fibrous Histiocytoma; Atypical Fibroxanthoma; Clear Cell Sarcoma of Soft Tissue; Epithelioid Malignant Peripheral Nerve Sheath Tumor; Epithelioid Sarcoma; Extraskeletal Myxoid Chondrosarcoma; Extraskeletal Osteosarcoma; Fibrohistiocytic Neoplasm; Fibrosarcoma; Inflammatory Myofibroblastic Tumor; Intimal Sarcoma; Leiomyosarcoma; Liposarcoma; Liver Embryonal Sarcoma; Low Grade Fibromyxoid Sarcoma; Low Grade Myofibroblastic Sarcoma; Malignant Peripheral Nerve Sheath Tumor; Malignant Skin Granular Cell Tumor; Malignant Triton Tumor; Mesenchymal Chondrosarcoma; Myxofibrosarcoma; Myxoid Chondrosarcoma; Myxoinflammatory Fibroblastic Sarcoma; Nerve Sheath Neoplasm; PEComa; Pericytic Neoplasm; Plexiform Fibrohistiocytic Tumor; Sclerosing Epithelioid Fibrosarcoma; Skin Glomus Tumor; Stage IB Soft Tissue Sarcoma AJCC v7; Stage IIB Soft Tissue Sarcoma AJCC v7; Stage III Soft Tissue Sarcoma AJCC v7; Stage IV Soft Tissue Sarcoma AJCC v7; Synovial Sarcoma; Undifferentiated High Grade Pleomorphic Sarcoma of Bone |
National Cancer Institute (NCI) |
2014-08-12 | PHASE2; PHASE3 |
| NCT01889069 | COMPLETED | Lymphoma |
Hoffmann-La Roche |
2013-07-31 | PHASE3 |
| NCT02951728 | UNKNOWN | Diffuse Large B Cell Lymphoma |
Ruijin Hospital |
2016-10 | PHASE1; PHASE2 |
| NCT01670500 | COMPLETED | Breast Cancer |
Beth Israel Deaconess Medical Center |
2012-10 | PHASE2 |
| NCT03283696 | COMPLETED | Soft Tissue Sarcoma |
Eli Lilly and Company |
2017-10-18 | PHASE1 |
| NCT02101788 | COMPLETED | Borderline Ovarian Serous Tumor; Micropapillary Serous Carcinoma; Ovarian Serous Adenocarcinoma; Primary Peritoneal Serous Adenocarcinoma; Recurrent Ovarian Low Grade Serous Adenocarcinoma; Recurrent Primary Peritoneal Serous Adenocarcinoma |
National Cancer Institute (NCI) |
2014-04-11 | PHASE2; PHASE3 |
| NCT02098343 | COMPLETED | Platinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53 |
Aprea Therapeutics |
2014-03 | PHASE1; PHASE2 |
| NCT01190930 | COMPLETED | Acute Lymphoblastic Leukemia; Adult B Lymphoblastic Lymphoma; Ann Arbor Stage I B Lymphoblastic Lymphoma; Ann Arbor Stage II B Lymphoblastic Lymphoma; Childhood B Acute Lymphoblastic Leukemia; Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1; Childhood B Lymphoblastic Lymphoma; Down Syndrome; Hypodiploid B Acute Lymphoblastic Leukemia; Philadelphia Chromosome Positive |
Children's Oncology Group |
2010-08-11 | PHASE3 |
| NCT02557854 | WITHDRAWN | Rhabdomyosarcoma; Neuroblastoma; Sarcoma; Sarcoma, Ewing; Osteosarcoma; Desmoid |
Theodore Laetsch |
2016-12 | PHASE1 |
| NCT01446809 | COMPLETED | Stage IIA Adult Soft Tissue Sarcoma; Stage III Adult Soft Tissue Sarcoma; Stage IV Adult Soft Tissue Sarcoma |
University of Washington |
2012-04 | |
| NCT02631876 | COMPLETED | Epithelial Ovarian Cancer; Primary Peritoneal Carcinoma; Fallopian Tube Cancer; Ovarian Cancer |
ImmunoGen, Inc. |
2016-03-02 | PHASE3 |
| NCT03387943 | UNKNOWN | Poorly Differentiated Thyroid Carcinoma |
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. |
2017-03-06 | PHASE2 |
| NCT01992653 | COMPLETED | Lymphoma, Non Hodgkin |
Genentech, Inc. |
2013-11-29 | PHASE1; PHASE2 |
| NCT02541565 | COMPLETED | Composite Lymphoma; Grade 3b Follicular Lymphoma; Stage I Diffuse Large B-Cell Lymphoma; Stage I Follicular Lymphoma; Stage II Diffuse Large B-Cell Lymphoma; Stage II Follicular Lymphoma; Stage III Diffuse Large B-Cell Lymphoma; Stage III Follicular Lymphoma; Stage IV Diffuse Large B-Cell Lymphoma; Stage IV Follicular Lymphoma |
University of Washington |
2015-11-24 | PHASE1 |
| NCT02414568 | COMPLETED | Classical Hodgkin Lymphoma |
The Lymphoma Academic Research Organisation |
2015-07-17 | PHASE2 |
| NCT02451943 | COMPLETED | Soft Tissue Sarcoma |
Eli Lilly and Company |
2015-09-14 | PHASE3 |
| NCT02562378 | COMPLETED | Breast Cancer |
MedSIR |
2015-10 | PHASE1 |
| NCT02994251 | TERMINATED | Unresectable Intrahepatic Cholangiocarcinoma |
Yale University |
2017-06-21 | PHASE2 |
| NCT02421588 | COMPLETED | Ovarian Cancer |
PharmaMar |
2015-05 | PHASE3 |
| NCT02548780 | COMPLETED | HCC; Hepatocellular Carcinoma |
Terumo Europe N.V. |
2016-04 | |
| NCT02912702 | UNKNOWN | Hemophagocytic Lymphohistiocytosis |
Beijing Friendship Hospital |
2016-09 | PHASE3 |
| NCT02903524 | UNKNOWN | Breast Cancer |
Hebei Medical University Fourth Hospital |
2016-09 | PHASE4 |
| NCT02412670 | COMPLETED | High Grade Upper Tract Urothelial Carcinoma |
ECOG-ACRIN Cancer Research Group |
2015-08-27 | PHASE2 |
| NCT00278421 | COMPLETED | Lymphoma |
German High-Grade Non-Hodgkin's Lymphoma Study Group |
2005-11 | PHASE3 |
| NCT01533207 | TERMINATED | Stage I Uterine Sarcoma AJCC v7; Uterine Corpus Leiomyosarcoma |
Gynecologic Oncology Group |
2012-06-04 | PHASE3 |
| NCT03188198 | UNKNOWN | Large B Cell Lymphoma |
Mansoura University |
2016-06-01 | PHASE2 |
| NCT02622074 | COMPLETED | Triple Negative Breast Neoplasms |
Merck Sharp & Dohme LLC |
2016-01-27 | PHASE1 |
| NCT01527149 | COMPLETED | Stage I Mantle Cell Lymphoma; Stage II Contiguous Mantle Cell Lymphoma; Stage II Non-Contiguous Mantle Cell Lymphoma; Stage III Mantle Cell Lymphoma; Stage IV Mantle Cell Lymphoma |
Roswell Park Cancer Institute |
2011-12-06 | PHASE2 |
| NCT03425656 | COMPLETED | Malignant Neoplasm of Breast |
AryoGen Pharmed Co. |
2016-07-09 | PHASE3 |
| NCT03211117 | COMPLETED | Thyroid Gland Undifferentiated (Anaplastic) Carcinoma |
Mayo Clinic |
2017-08-14 | PHASE2 |
| NCT00856037 | COMPLETED | Recurrent Small Cell Lung Carcinoma |
University of Nebraska |
2009-02-02 | PHASE1 |
| NCT00278408 | COMPLETED | Lymphoma |
German High-Grade Non-Hodgkin's Lymphoma Study Group |
2006-01-02 | PHASE3 |
| NCT01846611 | COMPLETED | Ovarian Neoplasms; Peritoneal Neoplasms; Fallopian Tube Neoplasms |
Janssen Research & Development, LLC |
2013-10-16 | PHASE3 |
| NCT01246063 | COMPLETED | Multiple Myeloma |
Washington University School of Medicine |
2012-05-14 | PHASE1; PHASE2 |
| NCT02293109 | COMPLETED | Contiguous Stage II Adult Lymphoblastic Lymphoma; Noncontiguous Stage II Adult Lymphoblastic Lymphoma; Stage I Adult Lymphoblastic Lymphoma; Stage III Adult Lymphoblastic Lymphoma; Stage IV Adult Lymphoblastic Lymphoma; Untreated Adult Acute Lymphoblastic Leukemia |
Mehrdad Abedi, MD |
2015-12-17 | PHASE1 |
| NCT02631109 | UNKNOWN | Hemophagocytic Lymphohistiocytosis |
Beijing Friendship Hospital |
2015-12 | PHASE3 |
| NCT01156883 | COMPLETED | Leukemia |
Gruppo Italiano Malattie EMatologiche dell'Adulto |
2010-04 | |
| NCT00408005 | COMPLETED | T Acute Lymphoblastic Leukemia; T Lymphoblastic Lymphoma |
National Cancer Institute (NCI) |
2007-01-30 | PHASE3 |
| NCT02494713 | TERMINATED | Prostate Cancer |
The University of Texas Health Science Center, Houston |
2015-10 | PHASE2 |
| NCT02560051 | TERMINATED | Prostatic Neoplasms |
The University of Texas Health Science Center, Houston |
2015-11 | PHASE2 |
| NCT00290498 | COMPLETED | Lymphoma |
M.D. Anderson Cancer Center |
2005-08-01 | PHASE2 |
| NCT01375699 | COMPLETED | Breast Cancer; Gastrointestinal Cancer; Genitourinary Cancer; Sarcoma; Gynecologic Cancer |
Virginia Commonwealth University |
2011-08-11 | PHASE1 |
| NCT01147016 | TERMINATED | Breast Cancer |
Barbara Ann Karmanos Cancer Institute |
2010-07 | PHASE2 |
| NCT00801281 | COMPLETED | Follicular Lymphoma; Marginal Zone Lymphoma; Small Lymphocytic Lymphoma; Lymphoplasmacytic Lymphoma |
Polish Lymphoma Research Group |
2007-02 | PHASE3 |
| NCT02419469 | TERMINATED | Leukemia; Precursor-B Acute Lymphoblastic Leukemia; Lymphoblastic Lymphoma; Lymphoma |
M.D. Anderson Cancer Center |
2015-11-13 | PHASE2 |
| NCT01145430 | COMPLETED | Estrogen Receptor Negative; HER2/Neu Negative; Male Breast Carcinoma; Progesterone Receptor Negative; Recurrent Breast Carcinoma; Recurrent Fallopian Tube Carcinoma; Recurrent Ovarian Carcinoma; Recurrent Primary Peritoneal Carcinoma; Stage IV Breast Cancer AJCC v6 and v7; Triple-Negative Breast Carcinoma |
National Cancer Institute (NCI) |
2010-06-01 | PHASE1 |
| NCT01655693 | COMPLETED | Carcinoma, Hepatocellular |
Valerio Therapeutics |
2012-06 | PHASE3 |
| NCT02096588 | TERMINATED | Breast Cancer; Stage I Breast Cancer; Stage II Breast Cancer; Stage III Breast Cancer |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2014-05-20 | PHASE2 |
| NCT01476410 | COMPLETED | Adult Lymphocyte Depletion Hodgkin Lymphoma; Adult Lymphocyte Predominant Hodgkin Lymphoma; Adult Mixed Cellularity Hodgkin Lymphoma; Adult Nodular Sclerosis Hodgkin Lymphoma; Stage II Adult Hodgkin Lymphoma; Stage III Adult Hodgkin Lymphoma; Stage IV Adult Hodgkin Lymphoma |
Northwestern University |
2011-11 | PHASE2 |
| NCT01876927 | COMPLETED | Gastric Cancer; Locally Advanced Malignant Neoplasm |
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS |
2010-09 | PHASE2 |
| NCT03339804 | COMPLETED | Breast Cancer; Chemotherapeutic Toxicity |
University of Sao Paulo General Hospital |
2016-02-22 | |
| NCT00526318 | UNKNOWN | Neuroblastoma |
German Society for Pediatric Oncology and Hematology GPOH gGmbH |
2007-01 | |
| NCT02292979 | COMPLETED | Hodgkin Lymphoma |
The Lymphoma Academic Research Organisation |
2015-03 | PHASE2 |
| NCT01193842 | COMPLETED | AIDS-Related Plasmablastic Lymphoma; AIDS-Related Primary Effusion Lymphoma; Ann Arbor Stage I Diffuse Large B-Cell Lymphoma; Ann Arbor Stage I Grade 3 Follicular Lymphoma; Ann Arbor Stage II Diffuse Large B-Cell Lymphoma; Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage III Diffuse Large B-Cell Lymphoma; Ann Arbor Stage III Grade 3 Follicular Lymphoma; Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma; Ann Arbor Stage IV Grade 3 Follicular Lymphoma; HIV Infection; Plasmablastic Lymphoma; Primary Effusion Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Grade 3 Follicular Lymphoma |
National Cancer Institute (NCI) |
2010-10-06 | PHASE1; PHASE2 |
| NCT01959490 | COMPLETED | Stage II Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer |
Case Comprehensive Cancer Center |
2013-09-24 | PHASE2 |
| NCT02125344 | COMPLETED | Tubular Breast Cancer Stage II; Tubular Breast Cancer Stage III; Mucinous Breast Cancer Stage II; Breast Cancer Female NOS; Invasive Ductal Breast Cancer; HER2 Positive Breast Cancer; Inflammatory Breast Cancer |
GBG Forschungs GmbH |
2014-12 | PHASE3 |
| NCT02261805 | TERMINATED | Cancer; Small Cell Lung Cancer |
Georgetown University |
2014-10 | PHASE1; PHASE2 |
| NCT01593228 | COMPLETED | Solid Tumors |
Sanofi |
2012-05 | PHASE3 |
| NCT00558519 | COMPLETED | Leukemia |
Alliance for Clinical Trials in Oncology |
2008-03-12 | PHASE2 |
| NCT01696032 | COMPLETED | Ovarian Cancer |
Astex Pharmaceuticals, Inc. |
2012-09 | PHASE2 |
| NCT01666444 | COMPLETED | Epithelial Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Cancer |
Celgene |
2012-10-31 | PHASE2 |
| NCT00575952 | COMPLETED | Endometrial Adenosquamous Carcinoma; Endometrial Clear Cell Adenocarcinoma; Endometrial Mixed Adenocarcinoma; Endometrial Serous Adenocarcinoma; Endometrial Squamous Cell Carcinoma; Endometrial Undifferentiated Carcinoma; Recurrent Uterine Corpus Carcinoma; Stage IIIA Uterine Corpus Cancer; Stage IIIC Uterine Corpus Cancer; Stage IVA Uterine Corpus Cancer; Stage IVB Uterine Corpus Cancer |
Gynecologic Oncology Group |
2008-01-17 | PHASE1 |
| NCT02531308 | TERMINATED | Diffuse Large B-Cell Lymphoma |
Rush University Medical Center |
2015-07 | PHASE2 |
| NCT00379340 | COMPLETED | Stage III Kidney Wilms Tumor; Stage IV Kidney Wilms Tumor |
Children's Oncology Group |
2007-04-30 | PHASE3 |
| NCT01459380 | COMPLETED | Ovarian Clear Cell Cystadenocarcinoma; Ovarian Endometrioid Adenocarcinoma; Ovarian Seromucinous Carcinoma; Ovarian Serous Cystadenocarcinoma; Recurrent Fallopian Tube Carcinoma; Recurrent Ovarian Carcinoma; Recurrent Primary Peritoneal Carcinoma; Undifferentiated Ovarian Carcinoma |
National Cancer Institute (NCI) |
2011-10-11 | PHASE1 |
| NCT00956930 | COMPLETED | Liver Cancer |
Northwestern University |
2009-08 | PHASE2 |
| NCT01055314 | COMPLETED | Adult Rhabdomyosarcoma; Childhood Alveolar Rhabdomyosarcoma; Childhood Embryonal Rhabdomyosarcoma; Metastatic Childhood Soft Tissue Sarcoma; Stage IV Adult Soft Tissue Sarcoma; Untreated Childhood Rhabdomyosarcoma |
National Cancer Institute (NCI) |
2010-01 | PHASE2 |
| NCT00450385 | TERMINATED | Lymphoma |
University of Miami |
2007-04-24 | PHASE2 |
| NCT03017404 | COMPLETED | Breast Cancer |
Hebei Medical University Fourth Hospital |
2015-05 | |
| NCT00920153 | TERMINATED | Lymphoma |
French Innovative Leukemia Organisation |
2008-05 | PHASE3 |
| NCT02785393 | COMPLETED | Substance-Related Disorders |
Baylor College of Medicine |
2011-03 | PHASE1 |
| NCT00381680 | COMPLETED | B-cell Childhood Acute Lymphoblastic Leukemia; L1 Childhood Acute Lymphoblastic Leukemia; L2 Childhood Acute Lymphoblastic Leukemia; Intermediate Risk Recurrent Childhood Acute Lymphoblastic Leukemia |
Children's Oncology Group |
2007-03 | PHASE3 |
| NCT01332968 | COMPLETED | Non-Hodgkin's Lymphoma |
Hoffmann-La Roche |
2011-07-06 | PHASE3 |
| NCT01132807 | COMPLETED | Lymphoma |
Alliance for Clinical Trials in Oncology |
2010-05 | PHASE2 |
| NCT01412879 | COMPLETED | Lymphoma |
SWOG Cancer Research Network |
2011-11 | PHASE2 |
| NCT00678327 | COMPLETED | Lymphoma |
University College, London |
2008-08-29 | PHASE3 |
| NCT02255110 | TERMINATED | Soft Tissue Sarcoma |
Merck KGaA, Darmstadt, Germany |
2014-12-10 | PHASE2 |
| NCT01839097 | COMPLETED | Peripheral T-cell Lymphoma |
Acrotech Biopharma Inc. |
2013-05 | PHASE1 |
| NCT00972478 | ACTIVE_NOT_RECRUITING | Ann Arbor Stage II Non-Hodgkin Lymphoma; Ann Arbor Stage III Non-Hodgkin Lymphoma; Ann Arbor Stage IV Non-Hodgkin Lymphoma |
National Cancer Institute (NCI) |
2010-11-15 | PHASE1; PHASE2 |
| NCT00470223 | ACTIVE_NOT_RECRUITING | Sarcoma |
UNICANCER |
2007-03 | PHASE3 |
| NCT02081495 | COMPLETED | Neoplasms |
Janssen Research & Development, LLC |
2014-08 | PHASE1 |
| NCT00634179 | COMPLETED | Lymphoma, B-Cell; Follicular Lymphoma |
Emory University |
2008-02 | PHASE1; PHASE2 |
| NCT01215344 | COMPLETED | Multiple Myeloma |
Vanderbilt-Ingram Cancer Center |
2010-11 | PHASE2 |
| NCT01100944 | TERMINATED | Thymoma; Thymic Carcinoma |
National Cancer Institute (NCI) |
2010-03-04 | PHASE1; PHASE2 |
| NCT00669877 | COMPLETED | Burkitt's Lymphoma; Burkitt'S-like Lymphoma |
M.D. Anderson Cancer Center |
2002-08 | PHASE2 |
| NCT00712881 | COMPLETED | Breast Cancer |
Cephalon, Inc. |
2008-10-13 | PHASE2 |
| NCT01333423 | WITHDRAWN | Breast Cancer |
M.D. Anderson Cancer Center |
2012-09 | PHASE1 |
| NCT02237690 | COMPLETED | Ovarian Cancer |
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. |
2014-09 | PHASE1 |
| NCT00931918 | COMPLETED | Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL) |
Millennium Pharmaceuticals, Inc. |
2009-10 | PHASE2 |
| NCT01946529 | COMPLETED | Desmoplastic Small Round Cell Tumor; Ewing Sarcoma of Bone or Soft Tissue; Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor; Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor |
St. Jude Children's Research Hospital |
2013-12-27 | PHASE2 |
| NCT00450801 | COMPLETED | Lymphoma |
University of Miami |
2004-04 | PHASE2 |
| NCT00107198 | COMPLETED | Ann Arbor Stage I Childhood Hodgkin Lymphoma; Ann Arbor Stage II Childhood Hodgkin Lymphoma; Childhood Nodular Lymphocyte Predominant B-Cell Lymphoma |
Children's Oncology Group |
2006-03-10 | PHASE2 |
| NCT01498588 | TERMINATED | Breast Neoplasms; Breast Cancer; Breast Tumors; Cancer of the Breast; Neoplasms, Breast; Tumors, Breast |
Emory University |
2011-11 | PHASE2 |
| NCT00923936 | COMPLETED | Sarcoma, Kaposi |
National Cancer Institute (NCI) |
2009-04-23 | PHASE2 |
| NCT02116530 | COMPLETED | Hematopoietic/Lymphoid Cancer; Nausea and Vomiting; Unspecified Adult Solid Tumor, Protocol Specific |
Alliance for Clinical Trials in Oncology |
2014-08-20 | PHASE3 |
| NCT00502411 | COMPLETED | Soft Tissue Sarcoma |
M.D. Anderson Cancer Center |
2003-01 | PHASE1 |
| NCT02260544 | COMPLETED | Ovarian Epithelial Cancer Recurrent |
Dr. Reddy's Laboratories Limited |
2014-07 | PHASE1 |
| NCT00567567 | COMPLETED | Localized Resectable Neuroblastoma; Localized Unresectable Neuroblastoma; Recurrent Neuroblastoma; Regional Neuroblastoma; Stage 4 Neuroblastoma; Stage 4S Neuroblastoma |
Children's Oncology Group |
2007-11-05 | PHASE3 |
| NCT00203502 | COMPLETED | Breast Cancer |
University of Arkansas |
2005-09 | PHASE2 |
| NCT00070564 | ACTIVE_NOT_RECRUITING | Breast Cancer |
SWOG Cancer Research Network |
2003-11 | PHASE3 |
| NCT00352534 | COMPLETED | Stage I Kidney Wilms Tumor; Stage II Kidney Wilms Tumor; Stage III Kidney Wilms Tumor |
Children's Oncology Group |
2006-11-06 | PHASE3 |
| NCT01489371 | COMPLETED | Ovarian Clear Cell Cystadenocarcinoma; Ovarian Endometrioid Adenocarcinoma; Ovarian Seromucinous Carcinoma; Ovarian Serous Cystadenocarcinoma; Ovarian Undifferentiated Carcinoma; Recurrent Fallopian Tube Carcinoma; Recurrent Ovarian Carcinoma; Recurrent Primary Peritoneal Carcinoma |
Gynecologic Oncology Group |
2012-07-09 | PHASE1 |
| NCT01815294 | COMPLETED | Neoplasms; Neoplasms, Ovarian; Neoplasms, Breast; Advanced or Refractory Solid Malignancies |
Janssen Research & Development, LLC |
2013-05 | PHASE1 |
| NCT00021255 | COMPLETED | Breast Neoplasms |
Sanofi |
2001-04 | PHASE3 |
| NCT01111903 | COMPLETED | Ovarian Cancer Recurrent |
ARCAGY/ GINECO GROUP |
2009-05 | PHASE1; PHASE2 |
| NCT01220128 | TERMINATED | Neoplasms, Breast |
GlaxoSmithKline |
2011-04-11 | PHASE2 |
| NCT01324076 | UNKNOWN | Liver Cancer |
University College, London |
2010-11 | PHASE3 |
| NCT00513955 | COMPLETED | Lymphoma |
University Hospital Plymouth NHS Trust |
2006-06 | PHASE2 |
| NCT00346164 | COMPLETED | Adult Alveolar Soft-part Sarcoma; Adult Angiosarcoma; Adult Epithelioid Sarcoma; Adult Extraskeletal Chondrosarcoma; Adult Extraskeletal Osteosarcoma; Adult Fibrosarcoma; Adult Leiomyosarcoma; Adult Liposarcoma; Adult Malignant Fibrous Histiocytoma; Adult Malignant Hemangiopericytoma; Adult Malignant Mesenchymoma; Adult Neurofibrosarcoma; Adult Synovial Sarcoma; Childhood Alveolar Soft-part Sarcoma; Childhood Angiosarcoma; Childhood Epithelioid Sarcoma; Childhood Fibrosarcoma; Childhood Leiomyosarcoma; Childhood Liposarcoma; Childhood Malignant Mesenchymoma; Childhood Neurofibrosarcoma; Childhood Synovial Sarcoma; Dermatofibrosarcoma Protuberans; Metastatic Childhood Soft Tissue Sarcoma; Nonmetastatic Childhood Soft Tissue Sarcoma; Stage I Adult Soft Tissue Sarcoma; Stage II Adult Soft Tissue Sarcoma; Stage III Adult Soft Tissue Sarcoma; Stage IV Adult Soft Tissue Sarcoma |
Children's Oncology Group |
2007-02-05 | PHASE3 |
| NCT00873093 | COMPLETED | B-cell Adult Acute Lymphoblastic Leukemia; B-cell Childhood Acute Lymphoblastic Leukemia; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Lymphoblastic Lymphoma; T-cell Adult Acute Lymphoblastic Leukemia; T-cell Childhood Acute Lymphoblastic Leukemia |
National Cancer Institute (NCI) |
2009-03 | PHASE2 |
| NCT01658358 | TERMINATED | Metastatic Breast Cancer |
China Medical University Hospital |
2012-07 | PHASE1; PHASE2 |
| NCT00002601 | COMPLETED | Sarcoma |
City of Hope Medical Center |
1994-09 | PHASE2 |
| NCT00101010 | COMPLETED | Lymphoma |
M.D. Anderson Cancer Center |
2005-09 | PHASE2 |
| NCT00024167 | TERMINATED | Prostate Cancer |
M.D. Anderson Cancer Center |
2002-04 | PHASE3 |
| NCT00861705 | COMPLETED | Male Breast Carcinoma; Stage IIA Breast Cancer AJCC v6 and v7; Stage IIB Breast Cancer AJCC v6 and v7; Stage IIIA Breast Cancer AJCC v7; Triple-Negative Breast Carcinoma |
National Cancer Institute (NCI) |
2009-07-21 | PHASE2 |
| NCT00400946 | COMPLETED | Drug/Agent Toxicity by Tissue/Organ; Leukemia |
Dana-Farber Cancer Institute |
2005-04 | PHASE3 |
| NCT00976911 | COMPLETED | Ovarian Cancer |
Hoffmann-La Roche |
2009-10-29 | PHASE3 |
| NCT01294293 | COMPLETED | Malignant Ovarian Mixed Epithelial Tumor; Ovarian Brenner Tumor; Ovarian Clear Cell Cystadenocarcinoma; Ovarian Endometrioid Adenocarcinoma; Ovarian Mucinous Cystadenocarcinoma; Ovarian Serous Cystadenocarcinoma; Recurrent Fallopian Tube Carcinoma; Recurrent Ovarian Carcinoma; Recurrent Primary Peritoneal Carcinoma; Undifferentiated Ovarian Carcinoma |
Gynecologic Oncology Group |
2011-03 | PHASE1 |
| NCT00038610 | COMPLETED | Leukemia |
M.D. Anderson Cancer Center |
2001-03 | PHASE2 |
| NCT01313884 | TERMINATED | Bone Cancer; Ewing's Sarcoma |
Stanford University |
2011-05 | PHASE2 |
| NCT00866307 | COMPLETED | Acute Lymphoblastic Leukemia; Adult B Acute Lymphoblastic Leukemia; Childhood B Acute Lymphoblastic Leukemia |
Children's Oncology Group |
2009-02-23 | PHASE1 |
| NCT00632827 | TERMINATED | Peripheral T-Cell Lymphoma |
University of California, San Francisco |
2008-07-01 | PHASE2 |
| NCT01100372 | UNKNOWN | Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer |
Medical University Innsbruck |
2009-07 | PHASE2 |
| NCT01969032 | COMPLETED | Triple Negative Breast Cancer |
Russian Academy of Medical Sciences |
2011-08 | PHASE2 |
| NCT00944047 | COMPLETED | Breast Cancer |
University of Kansas Medical Center |
2009-07 | PHASE2 |
| NCT01514188 | COMPLETED | Metastatic Soft Tissue Sarcoma; Locally Advanced Soft Tissue Sarcoma; Unresectable Soft Tissue Sarcoma |
ImmunityBio, Inc. |
2012-01-11 | PHASE2 |
| NCT00895414 | COMPLETED | Breast Cancer |
Masonic Cancer Center, University of Minnesota |
2009-04 | |
| NCT01659554 | TERMINATED | Recurrent Ovarian Cancer; Fallopian Tube Cancer |
Columbia University |
2012-03 | PHASE2 |
| NCT00014222 | COMPLETED | Breast Cancer |
NCIC Clinical Trials Group |
2000-12-04 | PHASE3 |
| NCT01078441 | TERMINATED | Refractory Multiple Myeloma |
National Cancer Institute (NCI) |
2010-09 | PHASE2 |
| NCT00433511 | ACTIVE_NOT_RECRUITING | Breast Adenocarcinoma |
National Cancer Institute (NCI) |
2007-11-02 | PHASE3 |
| NCT01415765 | WITHDRAWN | Lymphoma, Diffuse Large-Cell B-cell; Diffuse, Large B-cell Lymphoma; Lymphoma, Diffuse Large-Cell; Large-Cell Lymphoma, Diffuse |
National Cancer Institute (NCI) |
2011-07-15 | PHASE1; PHASE2 |
| NCT00028756 | COMPLETED | Stage III Bladder Cancer; Stage IV Bladder Cancer; Transitional Cell Carcinoma of the Bladder |
European Organisation for Research and Treatment of Cancer - EORTC |
2001-10 | PHASE3 |
| NCT00103285 | COMPLETED | Acute Lymphoblastic Leukemia; Childhood B Acute Lymphoblastic Leukemia |
Children's Oncology Group |
2005-04-11 | PHASE3 |
| NCT01332669 | COMPLETED | Hepatocellular Carcinoma |
Seoul National University Hospital |
2011-04 | PHASE4 |
| NCT00004092 | COMPLETED | Breast Cancer |
City of Hope Medical Center |
1999-05 | PHASE2 |
| NCT00290667 | COMPLETED | Lymphoma |
German High-Grade Non-Hodgkin's Lymphoma Study Group |
2004-02 | PHASE2 |
| NCT00107380 | COMPLETED | Lymphoma |
SWOG Cancer Research Network |
2005-11 | PHASE2 |
| NCT00662233 | COMPLETED | Ovarian Cancer; Sarcoma |
Mayo Clinic |
1991-10 | EARLY_PHASE1 |
| NCT00254592 | COMPLETED | Breast Cancer |
University of California, Irvine |
2005-10 | PHASE2 |
| NCT01004991 | COMPLETED | Diffuse Large B Cell Lymphoma |
Weill Medical College of Cornell University |
2010-01 | PHASE1; PHASE2 |
| NCT01328236 | UNKNOWN | Plasma Cell Leukemia; Multiple Myeloma |
Clinical Service, China |
2010-09 | PHASE2 |
| NCT00346125 | COMPLETED | Sarcoma |
Masonic Cancer Center, University of Minnesota |
2006-04-10 | |
| NCT00671658 | COMPLETED | Leukemia; Acute Lymphoblastic Leukemia |
M.D. Anderson Cancer Center |
2002-11 | PHASE2 |
| NCT00063999 | COMPLETED | Recurrent Uterine Corpus Carcinoma; Stage IIIA Uterine Corpus Cancer AJCC v7; Stage IIIB Uterine Corpus Cancer AJCC v7; Stage IIIC Uterine Corpus Cancer AJCC v7; Stage IVA Uterine Corpus Cancer AJCC v7; Stage IVB Uterine Corpus Cancer AJCC v7 |
GOG Foundation |
2003-08-25 | PHASE3 |
| NCT01640847 | WITHDRAWN | Painful Bone Metastases; Breast Carcinoma; Non-small Cell Lung Cancer; Small Cell Lung Cancer; Adenocarcinoma |
Imunon |
2012-07 | PHASE2 |
| NCT01605526 | COMPLETED | Sarcoma |
Hoffmann-La Roche |
2012-05 | PHASE1 |
| NCT00949182 | COMPLETED | Liver Cancer |
Rutgers, The State University of New Jersey |
2009-07 | PHASE2 |
| NCT01189253 | TERMINATED | Sarcoma |
European Organisation for Research and Treatment of Cancer - EORTC |
2011-05 | PHASE2; PHASE3 |
| NCT00002721 | COMPLETED | Prostate Cancer |
University of New Mexico |
1995-03 | PHASE1 |
| NCT00274924 | COMPLETED | Lymphoma |
Eastern Cooperative Oncology Group |
2006-09-26 | PHASE2 |
| NCT01639521 | WITHDRAWN | Anterior Urethral Cancer; Localized Transitional Cell Cancer of the Renal Pelvis and Ureter; Posterior Urethral Cancer; Recurrent Bladder Cancer; Recurrent Urethral Cancer; Regional Transitional Cell Cancer of the Renal Pelvis and Ureter; Stage III Bladder Cancer; Transitional Cell Carcinoma of the Bladder; Ureter Cancer; Urethral Cancer Associated With Invasive Bladder Cancer |
University of Southern California |
2013-05 | PHASE2 |
| NCT00617591 | COMPLETED | Multiple Myeloma |
H. Lee Moffitt Cancer Center and Research Institute |
2008-01 | PHASE2 |
| NCT01415336 | UNKNOWN | Breast Cancer |
Peking Union Medical College Hospital |
2010-03 | PHASE2; PHASE3 |
| NCT01005914 | TERMINATED | Leukemia |
OHSU Knight Cancer Institute |
2009-06 | PHASE2 |
| NCT01321775 | UNKNOWN | Breast Cancer |
Hospital Universitario Madrid Sanchinarro |
2009-08 | PHASE2 |
| NCT01095926 | COMPLETED | Wilms Tumor; Neuroblastoma; Soft Tissue Sarcoma; Acute Lymphoblastic Leukemia |
University Hospital Muenster |
2010-05 | PHASE2 |
| NCT00882206 | TERMINATED | Leukemia; Lymphoma |
Masonic Cancer Center, University of Minnesota |
2009-04 | PHASE2 |
| NCT00911183 | COMPLETED | Lymphoma |
Institut Bergonié |
2008-12-02 | PHASE2 |
| NCT01011010 | COMPLETED | Liver Cancer |
UNC Lineberger Comprehensive Cancer Center |
2009-07-22 | PHASE1 |
| NCT00376961 | COMPLETED | Lymphoma |
SWOG Cancer Research Network |
2006-08 | PHASE2 |
| NCT01104298 | TERMINATED | Sarcoma |
Grupo Espanol de Investigacion en Sarcomas |
2009-11 | PHASE2 |
| NCT00500422 | COMPLETED | Solid Tumors |
M.D. Anderson Cancer Center |
2005-01 | PHASE1 |
| NCT00878800 | COMPLETED | Dose Escalation: Solid Tumors; MTD: Soft Tissue Sarcomas |
Valerio Therapeutics |
2006-12 | PHASE1; PHASE2 |
| NCT00976131 | COMPLETED | Breast Cancer |
Columbia University |
2009-09 | PHASE1 |
| NCT00544219 | COMPLETED | Lymphoma |
Swiss Cancer Institute |
2007-09 | |
| NCT00666484 | COMPLETED | Lymphoma; Neurotoxicity |
University College, London |
2008-03 | PHASE2 |
| NCT01040871 | COMPLETED | Diffuse Large B-Cell Lymphoma |
Millennium Pharmaceuticals, Inc. |
2010-01 | PHASE2 |
| NCT00331955 | COMPLETED | Unspecified Adult Solid Tumor, Protocol Specific |
National Cancer Institute (NCI) |
2006-03 | PHASE1 |
| NCT00268853 | COMPLETED | Diffuse Large-Cell Lymphoma |
CTI BioPharma |
2005-11 | PHASE2 |
| NCT01099436 | COMPLETED | Breast Cancer |
Borstkanker Onderzoek Groep |
2010-04 | PHASE3 |
| NCT00182767 | COMPLETED | Fallopian Tube Cancer; Female Reproductive Cancer; Recurrent Breast Cancer; Recurrent Ovarian Epithelial Cancer; Stage III Ovarian Epithelial Cancer; Stage IV Breast Cancer; Stage IV Ovarian Epithelial Cancer |
National Cancer Institute (NCI) |
2006-01 | PHASE1; PHASE2 |
| NCT01259024 | TERMINATED | Hepatocellular Carcinoma |
Washington University School of Medicine |
2011-12 | |
| NCT00877006 | COMPLETED | Non-Hodgkin's Lymphoma; Mantle Cell Lymphoma |
Teva Branded Pharmaceutical Products R&D, Inc. |
2009-04-30 | PHASE3 |
| NCT00302003 | COMPLETED | Childhood Favorable Prognosis Hodgkin Lymphoma; Childhood Lymphocyte Depletion Hodgkin Lymphoma; Childhood Mixed Cellularity Hodgkin Lymphoma; Childhood Nodular Sclerosis Hodgkin Lymphoma; Stage I Childhood Hodgkin Lymphoma; Stage II Childhood Hodgkin Lymphoma |
Children's Oncology Group |
2006-02 | PHASE3 |
| NCT00006110 | COMPLETED | Breast Cancer |
UNC Lineberger Comprehensive Cancer Center |
1998-12 | PHASE2 |
| NCT01181999 | UNKNOWN | Lymphoma, Large B-cell, Diffuse |
Chonnam National University Hospital |
2010-08 | PHASE2 |
| NCT01131364 | TERMINATED | Advanced Solid Tumor; Breast Cancer |
Philogen S.p.A. |
2008-06 | PHASE1; PHASE2 |
| NCT00726700 | COMPLETED | Lymphoma |
Universität des Saarlandes |
2004-05 | PHASE2 |
| NCT00770536 | COMPLETED | Cancer; Carcinoma; Fallopian Tube Cancer; Gynecological Malignancies; Metastases; Oncology; Ovarian Cancer; Solid Tumors; Tumors |
Amgen |
2009-01 | PHASE1 |
| NCT00430118 | COMPLETED | Leukemia |
University Hospital Schleswig-Holstein |
2000-07 | PHASE3 |
| NCT00307294 | COMPLETED | Prostate Cancer |
University of Pittsburgh |
2006-03 | PHASE2 |
| NCT00392990 | COMPLETED | Lymphoma |
Northwestern University |
2007-02-06 | PHASE2 |
| NCT00969462 | COMPLETED | Non-Hodgkin's Lymphoma |
Meir Medical Center |
2009-09 | PHASE4 |
| NCT00744354 | TERMINATED | Multiple Myeloma and Plasma Cell Neoplasm |
UNC Lineberger Comprehensive Cancer Center |
2008-10 | PHASE1 |
| NCT00020566 | UNKNOWN | Sarcoma |
University of Leicester |
2001-02 | PHASE3 |
| NCT00544778 | TERMINATED | Sarcoma |
City of Hope Medical Center |
2001-08 | PHASE2 |
| NCT01258634 | TERMINATED | Osteosarcoma; Lung Metastases |
University of Chicago |
2010-07 | PHASE1 |
| NCT01673217 | COMPLETED | Recurrent Fallopian Tube Cancer; Recurrent Ovarian Epithelial Cancer; Recurrent Primary Peritoneal Cavity Cancer |
Roswell Park Cancer Institute |
2009-04 | PHASE1 |
| NCT00089544 | TERMINATED | Recurrent Adult Soft Tissue Sarcoma; Stage I Adult Soft Tissue Sarcoma AJCC v7; Stage II Adult Soft Tissue Sarcoma AJCC v7; Stage III Adult Soft Tissue Sarcoma AJCC v7 |
National Cancer Institute (NCI) |
2004-06-17 | PHASE2 |
| NCT00006721 | COMPLETED | Lymphoma |
SWOG Cancer Research Network |
2001-03 | PHASE3 |
| NCT00389818 | COMPLETED | Lymphoma |
AIDS Malignancy Consortium |
2007-01 | PHASE2 |
| NCT00002766 | COMPLETED | Leukemia; Lymphoma |
Memorial Sloan Kettering Cancer Center |
1996-03 | PHASE3 |
| NCT00785798 | TERMINATED | Relapsed Lymphomas; Refractory Lymphomas |
Yale University |
2009-01 | PHASE1; PHASE2 |
| NCT01329640 | TERMINATED | Locally Advanced HER2-positive Breast Cancer |
Instituto do Cancer do Estado de São Paulo |
2010-09 | PHASE2 |
| NCT00992706 | COMPLETED | Breast Cancer; Palmar-plantar Erythrodysesthesia |
Swiss Cancer Institute |
2009-09 | PHASE3 |
| NCT00903630 | TERMINATED | Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer |
Masonic Cancer Center, University of Minnesota |
2009-04 | PHASE1; PHASE2 |
| NCT00861120 | COMPLETED | Epithelial Ovarian Cancer |
Vejle Hospital |
2009-04 | PHASE2 |
| NCT00569257 | COMPLETED | Ovarian Cancer; Endometrial Cancer |
AEterna Zentaris |
2007-12 | PHASE2 |
| NCT00098579 | COMPLETED | Gastrointestinal Stromal Tumor; Recurrent Adult Soft Tissue Sarcoma; Stage IV Adult Soft Tissue Sarcoma |
National Cancer Institute (NCI) |
2004-10 | PHASE1 |
| NCT01110603 | TERMINATED | Cancer: Solid Tumors |
Tesaro, Inc. |
2010-07 | PHASE1 |
| NCT01055301 | WITHDRAWN | Multiple Myeloma; Plasma Cell Myeloma |
SWOG Cancer Research Network |
2011-07 | PHASE2 |
| NCT00703170 | COMPLETED | Resistant Solid Malignancies |
Washington University School of Medicine |
2008-03 | PHASE1 |
| NCT00048893 | TERMINATED | Breast Neoplasms; Metastases, Neoplasm |
National Cancer Institute (NCI) |
2002-11 | PHASE1; PHASE2 |
| NCT00509665 | COMPLETED | Head and Neck Cancer |
Medical University of South Carolina |
2005-06 | PHASE2 |
| NCT00507962 | COMPLETED | Advanced Cancer |
M.D. Anderson Cancer Center |
2005-03 | PHASE1 |
| NCT00379457 | UNKNOWN | Sarcoma |
European Paediatric Soft Tissue Sarcoma Study Group |
2006-06 | PHASE3 |
| NCT00877071 | COMPLETED | Hepatocellular Carcinoma |
University of Pittsburgh |
2008-11 | PHASE2 |
| NCT00290732 | COMPLETED | Breast Cancer |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2005-11 | PHASE1 |
| NCT00960336 | COMPLETED | Breast Cancer |
ARCAGY/ GINECO GROUP |
2008-03 | PHASE2 |
| NCT00003907 | COMPLETED | Liver Cancer; Metastatic Cancer |
Eastern Cooperative Oncology Group |
1999-12-15 | PHASE2 |
| NCT00983944 | WITHDRAWN | Lymphoma |
Ohio State University Comprehensive Cancer Center |
2009-09 | PHASE2 |
| NCT00458705 | COMPLETED | Multiple Myeloma and Plasma Cell Neoplasm |
Memorial Sloan Kettering Cancer Center |
2006-11 | PHASE2 |
| NCT00293397 | COMPLETED | Liver Cancer |
Yale University |
2005-11 | |
| NCT00366106 | TERMINATED | Multiple Myeloma |
Accelerated Community Oncology Research Network |
2006-07 | PHASE2 |
| NCT00194753 | COMPLETED | Breast Neoplasm |
University of Washington |
2001-12 | PHASE2 |
| NCT00896519 | UNKNOWN | Lymphoma |
French Innovative Leukemia Organisation |
2009-03 | PHASE2 |
| NCT00005047 | TERMINATED | Bladder Cancer |
SWOG Cancer Research Network |
1997-08 | PHASE3 |
| NCT00088881 | TERMINATED | Contiguous Stage II Adult Diffuse Large Cell Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Splenic Marginal Zone Lymphoma; Stage I Adult Diffuse Large Cell Lymphoma; Testicular Lymphoma; Waldenström Macroglobulinemia |
National Cancer Institute (NCI) |
2004-12 | PHASE2 |
| NCT00256243 | COMPLETED | Breast Cancer |
Rita Sanghvi, Mehta |
2004-04 | PHASE2 |
| NCT00148317 | COMPLETED | Multiple Myeloma |
Weill Medical College of Cornell University |
2005-06 | PHASE2 |
| NCT00671476 | UNKNOWN | Breast Cancer |
Dr. Susan Love Research Foundation |
2008-02 | |
| NCT01051362 | UNKNOWN | Non-small Cell Lung Cancer |
The First Affiliated Hospital of Guangzhou Medical University |
2006-02 | PHASE2 |
| NCT00837200 | TERMINATED | Non-hodgkins Lymphoma; Hodgkins Lymphoma; Multiple Myeloma |
Milton S. Hershey Medical Center |
2009-03 | PHASE2 |
| NCT00960063 | TERMINATED | Neoplasms; Solid Tumors; Bone Cancer; Kidney Tumor; Neuroblastoma |
Merck Sharp & Dohme LLC |
2009-11-11 | PHASE1 |
| NCT00121992 | COMPLETED | Breast Neoplasms |
Spanish Breast Cancer Research Group |
1999-07 | PHASE3 |
| NCT00524316 | TERMINATED | Liver Cancer |
Roswell Park Cancer Institute |
2007-04 | PHASE2 |
| NCT00363090 | UNKNOWN | Lymphoma |
Toronto Sunnybrook Regional Cancer Centre |
2006-09 | PHASE1; PHASE2 |
| NCT00121199 | COMPLETED | Contiguous Stage II Adult Diffuse Large Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma |
National Cancer Institute (NCI) |
2005-06 | PHASE2 |
| NCT00475683 | COMPLETED | Chemotherapy Induced Mucositis |
Hadassah Medical Organization |
2009-01 | PHASE3 |
| NCT00343863 | COMPLETED | Male Breast Cancer; Nausea and Vomiting; Stage I Breast Cancer; Stage II Breast Cancer; Stage IIIA Breast Cancer |
University of Washington |
2006-01 | |
| NCT00679029 | TERMINATED | HER2-negative Breast Cancer; Stage II Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer |
University of Nebraska |
2008-05-02 | PHASE2 |
| NCT00673179 | TERMINATED | Osteosarcoma |
M.D. Anderson Cancer Center |
2008-05 | |
| NCT00070018 | COMPLETED | Lymphoma |
SWOG Cancer Research Network |
2004-02 | PHASE2 |
| NCT01100359 | UNKNOWN | Endometrial Cancer |
Medical University Innsbruck |
2007-11 | PHASE2 |
| NCT00862836 | TERMINATED | Ovarian Cancer |
Genzyme, a Sanofi Company |
2009-04 | PHASE1; PHASE2 |
| NCT00801580 | UNKNOWN | Lymphoid Leukemia |
University of Bologna |
2008-03 | PHASE2 |
| NCT00550771 | COMPLETED | Breast Neoplasm |
Merck Sharp & Dohme LLC |
2007-07-16 | PHASE2 |
| NCT00742404 | UNKNOWN | Multiple Myeloma and Plasma Cell Neoplasm |
Oncotherapeutics |
2008-07 | PHASE2 |
| NCT00194779 | COMPLETED | Estrogen Receptor-negative Breast Cancer; Estrogen Receptor-positive Breast Cancer; HER2-positive Breast Cancer; Progesterone Receptor-negative Breast Cancer; Progesterone Receptor-positive Breast Cancer; Stage IA Breast Cancer; Stage IB Breast Cancer; Stage II Breast Cancer; Stage IIIA Breast Cancer |
University of Washington |
2003-10 | PHASE2 |
| NCT00365274 | TERMINATED | Anaplastic Large Cell Lymphoma |
National Cancer Institute (NCI) |
2006-08 | PHASE2 |
| NCT00061984 | COMPLETED | Sarcoma |
European Organisation for Research and Treatment of Cancer - EORTC |
2003-04 | PHASE3 |
| NCT00723658 | WITHDRAWN | Lymphoma |
SWOG Cancer Research Network |
2008-09 | PHASE2 |
| NCT00135499 | TERMINATED | Lymphoma, Large-Cell, Diffuse |
Lymphoma Study Association |
2001-10-16 | PHASE3 |
| NCT02168374 | COMPLETED | Dental Caries |
Aline R F de Castilho |
2008-03 | PHASE2 |
| NCT00618813 | COMPLETED | Ewing Sarcoma of Bone; Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor |
Children's Oncology Group |
2008-03 | |
| NCT00011986 | COMPLETED | Primary Peritoneal Carcinoma; Stage III Ovarian Cancer; Stage IV Ovarian Cancer |
Gynecologic Oncology Group |
2001-01 | PHASE3 |
| NCT00006011 | COMPLETED | Endometrial Adenocarcinoma; Endometrial Adenosquamous Carcinoma; Endometrial Clear Cell Adenocarcinoma; Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation; Endometrial Serous Adenocarcinoma; Stage III Uterine Corpus Cancer |
Gynecologic Oncology Group |
2000-07 | PHASE3 |
| NCT00039195 | COMPLETED | Lymphoma |
Memorial Sloan Kettering Cancer Center |
2006-11 | PHASE2 |
| NCT00392340 | UNKNOWN | Neuroblastoma |
Children's Cancer and Leukaemia Group |
2008-03 | PHASE2 |
| NCT00059839 | COMPLETED | Lymphoma |
Children's Oncology Group |
2003-11 | PHASE3 |
| NCT00455533 | COMPLETED | Breast Cancer |
Bristol-Myers Squibb |
2007-10 | PHASE2 |
| NCT00289809 | COMPLETED | Sarcoma, Soft Tissue |
Istituto Clinico Humanitas |
2006-09 | PHASE1; PHASE2 |
| NCT00533936 | UNKNOWN | Breast Cancer |
Instituto Nacional de Cancerologia, Columbia |
2006-09 | PHASE2 |
| NCT03055143 | COMPLETED | Breast Cancer and Ovarian Cancer |
Sun Pharma Advanced Research Company Limited |
2008-09-03 | PHASE1 |
| NCT00071058 | COMPLETED | Adrenal Cortex Neoplasms |
National Cancer Institute (NCI) |
2003-10 | PHASE2 |
| NCT00377559 | COMPLETED | Breast Cancer; Neoplasm Metastasis |
Catharina Ziekenhuis Eindhoven |
2006-05 | PHASE2 |
| NCT00720096 | TERMINATED | Ovarian Cancer |
H. Lee Moffitt Cancer Center and Research Institute |
2008-07 | |
| NCT00057811 | COMPLETED | Childhood Burkitt Lymphoma; Childhood Diffuse Large Cell Lymphoma; Childhood Immunoblastic Large Cell Lymphoma; Stage I Childhood Large Cell Lymphoma; Stage I Childhood Small Noncleaved Cell Lymphoma; Stage II Childhood Large Cell Lymphoma; Stage II Childhood Small Noncleaved Cell Lymphoma; Stage III Childhood Large Cell Lymphoma; Stage III Childhood Small Noncleaved Cell Lymphoma; Stage IV Childhood Large Cell Lymphoma; Stage IV Childhood Small Noncleaved Cell Lymphoma; Untreated Childhood Acute Lymphoblastic Leukemia |
Children's Oncology Group |
2004-06 | PHASE2 |
| NCT00003135 | UNKNOWN | Breast Cancer; Cervical Cancer; Endometrial Cancer; Ovarian Cancer |
The University of Texas Health Science Center, Houston |
1997-11 | PHASE2 |
| NCT00119262 | COMPLETED | Male Breast Cancer; Stage II Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer |
National Cancer Institute (NCI) |
2005-10 | PHASE2 |
| NCT00499083 | COMPLETED | Breast Cancer |
University of Nebraska |
2006-05-01 | PHASE2 |
| NCT00814541 | COMPLETED | Multiple Myeloma and Plasma Cell Neoplasm |
Cancer Trials Ireland |
2005-12 | PHASE2 |
| NCT00562068 | UNKNOWN | Lymphoma; Small Intestine Cancer |
Cancer Research UK |
2007-05 | PHASE1 |
| NCT00407888 | COMPLETED | Estrogen Receptor-positive Breast Cancer; HER2-positive Breast Cancer; Stage IA Breast Cancer; Stage IB Breast Cancer; Stage II Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer; Stage IV Breast Cancer |
University of Washington |
2006-05 | PHASE2 |
| NCT00886028 | UNKNOWN | Malignant Pleural Mesothelioma |
National Institute of Cancerología |
2006-09 | PHASE2 |
| NCT00494780 | COMPLETED | Lymphoma, Follicular |
GlaxoSmithKline |
2007-06 | PHASE2 |
| NCT00562185 | WITHDRAWN | Ovarian Cancer |
University of Texas Southwestern Medical Center |
2008-05 | PHASE1; PHASE2 |
| NCT00523380 | COMPLETED | Cancer; Ovarian Cancer |
Novo Nordisk A/S |
2007-10-04 | PHASE2 |
| NCT00426127 | TERMINATED | Pancreatic Cancer |
University of Iowa |
2006-11 | PHASE2 |
| NCT00478374 | COMPLETED | Hepatocellular Carcinoma |
University of Bern |
2007-05 | PHASE1 |
| NCT00047229 | COMPLETED | Liver Cancer |
University Health Network, Toronto |
2002-10 | PHASE2 |
| NCT00189553 | COMPLETED | Ovarian Cancer; Fallopian Tube Cancer |
ARCAGY/ GINECO GROUP |
2005-04 | PHASE3 |
| NCT00193037 | COMPLETED | Breast Cancer |
SCRI Development Innovations, LLC |
2001-02 | PHASE2 |
| NCT00025103 | UNKNOWN | Kidney Cancer |
Children's Cancer and Leukaemia Group |
2001-05 | PHASE2 |
| NCT00985907 | TERMINATED | Multiple Myeloma; Patient Participation |
University of California, San Francisco |
2004-10-28 | PHASE1; PHASE2 |
| NCT00441376 | COMPLETED | Hepatocellular Carcinoma; Liver Neoplasms |
Imunon |
2007-02 | PHASE1 |
| NCT00301821 | COMPLETED | Lymphoma |
Alliance for Clinical Trials in Oncology |
2006-01 | PHASE2 |
| NCT00337194 | COMPLETED | Adult Lymphocyte Depletion Hodgkin Lymphoma; Adult Lymphocyte Predominant Hodgkin Lymphoma; Adult Mixed Cellularity Hodgkin Lymphoma; Adult Nodular Sclerosis Hodgkin Lymphoma; Recurrent Adult Hodgkin Lymphoma |
National Cancer Institute (NCI) |
2006-04 | PHASE2 |
| NCT00445406 | COMPLETED | Breast Cancer |
Swiss Cancer Institute |
2006-12 | PHASE2 |
| NCT01396655 | COMPLETED | Breast Cancer |
Seoul National University Hospital |
2006-07 | PHASE2 |
| NCT00410462 | UNKNOWN | Ovarian Cancer; Sarcoma; Small Intestine Cancer |
European Organisation for Research and Treatment of Cancer - EORTC |
2006-10 | PHASE2 |
| NCT00244985 | COMPLETED | Lymphoma |
Roswell Park Cancer Institute |
2005-09 | PHASE1; PHASE2 |
| NCT00093834 | COMPLETED | Breast Cancer |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2004-01 | PHASE1 |
| NCT00102973 | COMPLETED | Ovarian Neoplasms |
Telik |
2004-12 | PHASE3 |
| NCT00003728 | UNKNOWN | Leukemia; Lymphoma |
European Organisation for Research and Treatment of Cancer - EORTC |
1998-12 | PHASE3 |
| NCT00470067 | TERMINATED | Endometrial Cancer |
Roswell Park Cancer Institute |
2007-02 | PHASE2 |
| NCT00245050 | COMPLETED | Breast Cancer; Drug/Agent Toxicity by Tissue/Organ; Endometrial Cancer; Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer |
Case Comprehensive Cancer Center |
2004-04 | PHASE3 |
| NCT00609765 | TERMINATED | Pancreatic Cancer |
H. Lee Moffitt Cancer Center and Research Institute |
2007-08 | PHASE2 |
| NCT00365417 | COMPLETED | Breast Cancer |
NSABP Foundation Inc |
2006-08 | PHASE2 |
| NCT00544765 | COMPLETED | Breast Cancer |
GBG Forschungs GmbH |
2002-09 | PHASE3 |
| NCT00063934 | TERMINATED | Male Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer; Stage IV Breast Cancer |
National Cancer Institute (NCI) |
2003-05 | PHASE1; PHASE2 |
| NCT00006184 | COMPLETED | Multiple Myeloma |
National Cancer Institute (NCI) |
2001-02-08 | PHASE2 |
| NCT00424203 | COMPLETED | Breast Cancer; Cognitive/Functional Effects; Depression; Malnutrition; Psychosocial Effects of Cancer and Its Treatment |
UNICANCER |
2006-01 | PHASE2 |
| NCT00005945 | COMPLETED | Leukemia |
Children's Oncology Group |
2000-06 | PHASE3 |
| NCT00041132 | COMPLETED | Lymphoma |
SWOG Cancer Research Network |
2002-09 | PHASE2 |
| NCT00161239 | TERMINATED | T-Cell Lymphoma |
University of Medicine and Dentistry of New Jersey |
2005-02 | |
| NCT00764907 | UNKNOWN | Leukemia |
University Hospital, Motol |
2002-11 | PHASE3 |
| NCT00097981 | COMPLETED | Multiple Myeloma |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
2005-01 | PHASE3 |
| NCT00025363 | COMPLETED | Alveolar Childhood Rhabdomyosarcoma; Embryonal Childhood Rhabdomyosarcoma; Embryonal-botryoid Childhood Rhabdomyosarcoma; Previously Treated Childhood Rhabdomyosarcoma; Recurrent Childhood Rhabdomyosarcoma |
National Cancer Institute (NCI) |
2001-11 | PHASE2 |
| NCT00004188 | COMPLETED | Neuroblastoma |
Children's Oncology Group |
2001-02 | PHASE3 |
| NCT00780039 | COMPLETED | Ovarian Neoplasms |
Merck Sharp & Dohme LLC |
2003-10-01 | PHASE2 |
| NCT00075634 | COMPLETED | Recurrent Neuroblastoma; Unspecified Childhood Solid Tumor, Protocol Specific |
National Cancer Institute (NCI) |
2003-12 | PHASE1 |
| NCT00336791 | COMPLETED | Breast Cancer |
M.D. Anderson Cancer Center |
2003-09 | PHASE3 |
| NCT00003342 | COMPLETED | Bladder Cancer; Transitional Cell Cancer of the Renal Pelvis and Ureter |
Memorial Sloan Kettering Cancer Center |
1997-12 | PHASE1 |
| NCT00093509 | COMPLETED | Sarcoma |
Mark Dewhirst |
1999-11 | PHASE1; PHASE2 |
| NCT00128778 | COMPLETED | Breast Neoplasms |
Spanish Breast Cancer Research Group |
2002-10-28 | PHASE4 |
| NCT00135135 | COMPLETED | Neuroblastoma |
St. Jude Children's Research Hospital |
2005-08 | PHASE2 |
| NCT00261313 | COMPLETED | Breast Cancer |
Amgen |
2005-12 | PHASE2 |
| NCT00043082 | COMPLETED | Ovarian Cancer; Peritoneal Cavity Cancer |
SWOG Cancer Research Network |
2002-08 | PHASE3 |
| NCT00004125 | COMPLETED | Breast Cancer |
Eastern Cooperative Oncology Group |
1999-11-16 | PHASE3 |
| NCT00146562 | COMPLETED | Breast Cancer; Stage I Breast Cancer; Stage II Breast Cancer |
Harold J. Burstein, MD, PhD |
2003-07 | PHASE2 |
| NCT00561743 | COMPLETED | Multiple Myeloma |
Janssen-Ortho Inc., Canada |
2005-11 | PHASE2 |
| NCT00003311 | COMPLETED | Lymphoma |
M.D. Anderson Cancer Center |
1998-05-20 | PHASE2 |
| NCT00002542 | COMPLETED | Breast Cancer |
NCIC Clinical Trials Group |
1993-07-20 | PHASE3 |
| NCT00002744 | COMPLETED | Leukemia |
Children's Oncology Group |
1996-05 | PHASE3 |
| NCT00003350 | COMPLETED | AIDS-related Kaposi Sarcoma |
National Cancer Institute (NCI) |
1999-03 | PHASE3 |
| NCT00002565 | COMPLETED | Lymphoma |
M.D. Anderson Cancer Center |
1994-05-25 | PHASE3 |
| NCT00176293 | TERMINATED | Prostate Cancer |
University of Kentucky |
2005-10 | PHASE2 |
| NCT00077103 | TERMINATED | Head and Neck Cancer |
Case Comprehensive Cancer Center |
2003-11 | PHASE1; PHASE2 |
| NCT00002715 | COMPLETED | Lymphoma |
Stanford University |
1989-04 | PHASE2 |
| NCT00003385 | COMPLETED | Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer |
Gynecologic Oncology Group |
1999-03 | PHASE1 |
| NCT00040872 | COMPLETED | Neuroblastoma |
Memorial Sloan Kettering Cancer Center |
2000-06 | PHASE2 |
| NCT00053768 | COMPLETED | Lymphoma |
German High-Grade Non-Hodgkin's Lymphoma Study Group |
2002-04 | PHASE3 |
| NCT00019864 | TERMINATED | Cardiac Toxicity; Sarcoma |
National Cancer Institute (NCI) |
2000-03 | PHASE2 |
| NCT00057720 | COMPLETED | Ovarian Neoplasms |
Telik |
2003-06 | PHASE3 |
| NCT00020943 | COMPLETED | Lymphoma |
Alliance for Clinical Trials in Oncology |
2001-06 | PHASE2 |
| NCT00041327 | COMPLETED | Lymphoma |
AIDS Malignancy Consortium |
2002-10 | PHASE2 |
| NCT00652860 | COMPLETED | Metastatic Cancer; Sarcoma |
Mayo Clinic |
2001-08 | PHASE2 |
| NCT00002676 | COMPLETED | Lymphoma |
Alliance for Clinical Trials in Oncology |
1995-07 | PHASE2 |
| NCT00201695 | COMPLETED | Multiple Myeloma |
Ohio State University Comprehensive Cancer Center |
2004-07 | PHASE2 |
| NCT00070200 | COMPLETED | Neuroblastoma |
Children's Oncology Group |
2004-03 | PHASE1 |
| NCT00052312 | COMPLETED | Endometrial Cancer |
European Organisation for Research and Treatment of Cancer - EORTC |
2002-09 | PHASE2 |
| NCT00016406 | COMPLETED | Breast Cancer |
SWOG Cancer Research Network |
2001-05 | PHASE3 |
| NCT00003093 | COMPLETED | Neuroblastoma |
Children's Oncology Group |
1988-03 | PHASE3 |
| NCT00006734 | COMPLETED | Sarcoma |
Children's Oncology Group |
2001-05 | PHASE3 |
| NCT00004231 | COMPLETED | Lymphoma |
Northwestern University |
1999-10 | PHASE2 |
| NCT00779285 | TERMINATED | Breast Neoplasm |
Merck Sharp & Dohme LLC |
2006-02 | PHASE4 |
| NCT00613457 | COMPLETED | Leukemia |
Associazione Italiana Ematologia Oncologia Pediatrica |
2000-09 | PHASE3 |
| NCT00007904 | COMPLETED | Breast Cancer |
Case Comprehensive Cancer Center |
2000-07 | PHASE2 |
| NCT00054158 | COMPLETED | Multiple Myeloma and Plasma Cell Neoplasm |
Roswell Park Cancer Institute |
2004-08 | PHASE2 |
| NCT00049569 | COMPLETED | L1 Childhood Acute Lymphoblastic Leukemia; L2 Childhood Acute Lymphoblastic Leukemia; Non-T, Non-B Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Lymphoblastic Leukemia; T-cell Childhood Acute Lymphoblastic Leukemia |
National Cancer Institute (NCI) |
2003-01 | |
| NCT00309881 | COMPLETED | Chronic Lymphocytic Leukemia |
German CLL Study Group |
2003-04 | PHASE2 |
| NCT00005964 | COMPLETED | Lymphoma |
Alliance for Clinical Trials in Oncology |
2000-05 | PHASE2 |
| NCT00003119 | COMPLETED | Neuroblastoma |
Children's Oncology Group |
1998-03 | PHASE3 |
| NCT00006235 | COMPLETED | Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer |
Gynecologic Oncology Group |
PHASE1 | |
| NCT00008242 | COMPLETED | Multiple Myeloma and Plasma Cell Neoplasm |
Memorial Sloan Kettering Cancer Center |
2000-08 | PHASE2 |
| NCT00165191 | COMPLETED | Adenocarcinoma of Stomach; Adenocarcinoma of GE Junction; Adenocarcinoma of Esophagus |
Dana-Farber Cancer Institute |
1998-08 | PHASE2 |
| NCT00005800 | COMPLETED | Breast Cancer |
H. Lee Moffitt Cancer Center and Research Institute |
1999-04 | PHASE2 |
| NCT00023998 | COMPLETED | Metastatic Osteosarcoma |
National Cancer Institute (NCI) |
2001-07 | PHASE2 |
| NCT00039481 | COMPLETED | Cardiac Toxicity; Unspecified Childhood Solid Tumor, Protocol Specific |
National Cancer Institute (NCI) |
2002-11 | PHASE1 |
| NCT00036790 | COMPLETED | Breast Cancer; Chronic Myeloproliferative Disorders; Colorectal Cancer; Head and Neck Cancer; Leukemia; Lung Cancer; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic/Myeloproliferative Diseases; Prostate Cancer; Small Intestine Cancer; Unspecified Adult Solid Tumor, Protocol Specific |
University of Wisconsin, Madison |
2002-02 | PHASE1 |
| NCT00017368 | COMPLETED | Neuroblastoma |
Children's Oncology Group |
2001-04 | PHASE2 |
| NCT00189410 | COMPLETED | Cancer of the Ovary Treated as 2nd Line Therapy; Muellerian Mixed Tumours; Tumours of the Uterus; Cervical Cancers; Non-Epithelial Ovarian Tumours |
AGO Study Group |
2003-06 | PHASE2 |
| NCT00014534 | COMPLETED | Bladder Cancer |
Alliance for Clinical Trials in Oncology |
2004-03 | PHASE3 |
| NCT00002855 | COMPLETED | Prostate Cancer |
M.D. Anderson Cancer Center |
1996-08 | PHASE3 |
| NCT00193115 | COMPLETED | Breast Cancer |
SCRI Development Innovations, LLC |
2004-03 | PHASE2 |
| NCT00461344 | TERMINATED | Ductal Carcinoma |
Sanofi |
2004-07 | PHASE2 |
| NCT00005090 | TERMINATED | Lymphoma |
SWOG Cancer Research Network |
2000-04 | PHASE3 |
| NCT00002466 | COMPLETED | Kidney Cancer; Sarcoma |
Memorial Sloan Kettering Cancer Center |
1990-05 | PHASE2 |
| NCT00005970 | COMPLETED | Breast Adenocarcinoma; HER2 Positive Breast Carcinoma; Stage IA Breast Cancer AJCC v7; Stage IB Breast Cancer AJCC v7; Stage IIA Breast Cancer AJCC v6 and v7; Stage IIB Breast Cancer AJCC v6 and v7; Stage IIIA Breast Cancer AJCC v7 |
National Cancer Institute (NCI) |
2000-05-19 | PHASE3 |
| NCT00006016 | COMPLETED | Adult Primary Hepatocellular Carcinoma; Advanced Adult Primary Liver Cancer; Localized Unresectable Adult Primary Liver Cancer |
National Cancer Institute (NCI) |
2000-05 | PHASE2 |
| NCT00005643 | COMPLETED | Endometrial Cancer; Sarcoma |
Gynecologic Oncology Group |
2000-05 | PHASE2 |
| NCT00030654 | COMPLETED | Prostate Cancer |
Radiation Therapy Oncology Group |
2002-10 | PHASE3 |
| NCT00032019 | COMPLETED | Lymphoma |
Alliance for Clinical Trials in Oncology |
2002-02 | PHASE2 |
| NCT00005089 | COMPLETED | Lymphoma |
SWOG Cancer Research Network |
2000-04 | PHASE2 |
| NCT00002827 | COMPLETED | Cardiac Toxicity; Lymphoma |
Children's Oncology Group |
1996-10 | PHASE3 |
| NCT00060385 | TERMINATED | Lymphoma |
European Organisation for Research and Treatment of Cancer - EORTC |
2003-03 | PHASE2; PHASE3 |
| NCT00003105 | COMPLETED | Bladder Cancer; Transitional Cell Cancer of the Renal Pelvis and Ureter |
Memorial Sloan Kettering Cancer Center |
1997-09 | PHASE1; PHASE2 |
| NCT00006825 | COMPLETED | Breast Cancer |
NYU Langone Health |
2000-07 | PHASE1; PHASE2 |
| NCT00003691 | COMPLETED | Endometrial Cancer |
Gynecologic Oncology Group |
1998-12 | PHASE3 |
| NCT00080782 | TERMINATED | Metastatic Cancer; Prostate Cancer |
M.D. Anderson Cancer Center |
2002-02 | PHASE2 |
| NCT00004179 | COMPLETED | Lymphoma |
European Organisation for Research and Treatment of Cancer - EORTC |
1999-05 | PHASE3 |
| NCT00002700 | COMPLETED | Leukemia; Lymphoma |
European Organisation for Research and Treatment of Cancer - EORTC |
1995-08 | PHASE3 |
| NCT00002494 | COMPLETED | Leukemia; Lymphoma |
Alliance for Clinical Trials in Oncology |
1992-05 | PHASE2 |
| NCT00003937 | COMPLETED | Cardiac Toxicity; Sarcoma |
Children's Oncology Group |
1999-09 | PHASE3 |
| NCT00004930 | COMPLETED | Lung Cancer; Metastatic Cancer |
Memorial Sloan Kettering Cancer Center |
1999-07 | PHASE1 |
| NCT00009997 | COMPLETED | Breast Cancer |
NYU Langone Health |
1999-03 | PHASE1 |
| NCT00074139 | WITHDRAWN | Breast Cancer |
Case Comprehensive Cancer Center |
2003-09 | PHASE1 |
| NCT00002657 | COMPLETED | Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm |
SWOG Cancer Research Network |
1995-05 | PHASE2 |
| NCT00016341 | TERMINATED | Endometrial Cancer |
Gynecologic Oncology Group |
2001-05 | PHASE3 |
| NCT00002757 | COMPLETED | Leukemia; Lymphoma |
Children's Oncology Group |
2001-06 | PHASE3 |
| NCT00004010 | COMPLETED | Lymphoma |
Children's Oncology Group |
1999-10 | PHASE2 |
| NCT00002548 | COMPLETED | Multiple Myeloma |
SWOG Cancer Research Network |
1994-01 | PHASE3 |
| NCT00023855 | COMPLETED | Unspecified Adult Solid Tumor, Protocol Specific |
University of Wisconsin, Madison |
2001-06 | PHASE1 |
| NCT00004925 | COMPLETED | Breast Cancer |
Memorial Sloan Kettering Cancer Center |
1999-08 | PHASE1; PHASE2 |
| NCT00006372 | COMPLETED | Unspecified Adult Solid Tumor, Protocol Specific |
Case Comprehensive Cancer Center |
2000-02 | PHASE1 |
| NCT00002878 | COMPLETED | Multiple Myeloma and Plasma Cell Neoplasm |
Eastern Cooperative Oncology Group |
1997-06-30 | PHASE3 |
| NCT00014352 | COMPLETED | Prostate Cancer; Thromboembolism |
Memorial Sloan Kettering Cancer Center |
2000-09 | PHASE2 |
| NCT00072007 | COMPLETED | Leukemia |
Swiss Cancer Institute |
2002-06 | PHASE2 |
| NCT00005991 | COMPLETED | Breast Cancer |
M.D. Anderson Cancer Center |
1997-08-25 | PHASE2 |
| NCT00003133 | COMPLETED | Bladder Cancer; Transitional Cell Cancer of the Renal Pelvis and Ureter |
Memorial Sloan Kettering Cancer Center |
1997-09 | PHASE1 |
| NCT00003038 | COMPLETED | Adrenocortical Carcinoma; Breast Cancer; Colorectal Cancer; Prostate Cancer; Unspecified Adult Solid Tumor, Protocol Specific |
Mayo Clinic |
1997-10 | PHASE1 |
| NCT00006377 | COMPLETED | Endometrial Cancer |
Memorial Sloan Kettering Cancer Center |
2000-06 | PHASE2 |
| NCT00005822 | COMPLETED | Breast Cancer |
Case Comprehensive Cancer Center |
2000-04 | PHASE1 |
| NCT00002539 | COMPLETED | Sarcoma |
European Organisation for Research and Treatment of Cancer - EORTC |
1993-08 | PHASE3 |
| NCT00003207 | COMPLETED | Sarcoma; Unspecified Adult Solid Tumor, Protocol Specific |
Washington University School of Medicine |
1998-03 | PHASE1 |
| NCT00003380 | TERMINATED | Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer |
Gynecologic Oncology Group |
1998-05 | PHASE1 |
| NCT00002489 | COMPLETED | Extragonadal Germ Cell Tumor; Ovarian Cancer |
Memorial Sloan Kettering Cancer Center |
1991-10 | PHASE2 |
| NCT00002611 | COMPLETED | Kidney Cancer |
Children's Oncology Group |
1995-07 | PHASE3 |
| NCT00002610 | COMPLETED | Kidney Cancer |
Children's Oncology Group |
1996-01 | PHASE3 |
| NCT00008073 | COMPLETED | Unspecified Adult Solid Tumor, Protocol Specific |
University of Pittsburgh |
1996-01 | PHASE1 |
| NCT00016172 | COMPLETED | Lymphoma; Small Intestine Cancer; Unspecified Adult Solid Tumor, Protocol Specific |
Memorial Sloan Kettering Cancer Center |
2000-11 | PHASE1 |
| NCT00002679 | COMPLETED | Breast Cancer |
Yale University |
1994-02 | PHASE2 |
| NCT00002837 | COMPLETED | Breast Cancer |
M.D. Anderson Cancer Center |
1995-09 | PHASE1; PHASE2 |
| NCT00002665 | COMPLETED | Leukemia; Neutropenia; Thrombocytopenia |
SWOG Cancer Research Network |
1995-07 | PHASE2 |
| NCT00003701 | COMPLETED | Bladder Cancer; Urethral Cancer |
Eastern Cooperative Oncology Group |
1999-04-02 | PHASE3 |
| NCT00004123 | COMPLETED | Sarcoma |
M.D. Anderson Cancer Center |
1997-07 | PHASE1 |
| NCT00003035 | COMPLETED | Breast Cancer |
Georgetown University |
1997-03 | PHASE2 |
| NCT00002493 | COMPLETED | Endometrial Cancer; Psychosocial Effects of Cancer and Its Treatment |
Gynecologic Oncology Group |
1992-05 | PHASE3 |
| NCT00003682 | TERMINATED | Prostate Cancer |
UNICANCER |
1998-10 | PHASE3 |
| NCT00003847 | TERMINATED | Lung Cancer |
Vertex Pharmaceuticals Incorporated |
1998-12 | PHASE2 |
| NCT00003086 | TERMINATED | Breast Cancer |
Louisiana State University Health Sciences Center Shreveport |
1997-03 | PHASE1; PHASE2 |
| NCT00004030 | COMPLETED | Unspecified Adult Solid Tumor, Protocol Specific |
Georgetown University |
1996-03 | PHASE1; PHASE2 |
| NCT00004162 | COMPLETED | Lymphoma |
University of Alabama at Birmingham |
1997-06 | PHASE1 |
| NCT00003683 | COMPLETED | Kidney Cancer |
UNICANCER |
1998-03 | PHASE2 |
| NCT00002764 | COMPLETED | Endometrial Cancer; Kidney Cancer; Metastatic Cancer; Ovarian Cancer; Pheochromocytoma; Sarcoma |
European Organisation for Research and Treatment of Cancer - EORTC |
1996-04 | PHASE3 |
| NCT00003352 | COMPLETED | Breast Cancer |
NSABP Foundation Inc |
1998-06 | PHASE2 |
| NCT00002618 | COMPLETED | Lymphoma |
Children's Oncology Group |
1994-12 | PHASE3 |
| NCT00002865 | COMPLETED | Leukemia |
Wake Forest University Health Sciences |
1995-04 | PHASE2 |
| NCT00002462 | ACTIVE_NOT_RECRUITING | Lymphoma |
European Organisation for Research and Treatment of Cancer - EORTC |
1989-09 | PHASE3 |
| NCT00003776 | COMPLETED | Sarcoma |
Memorial Sloan Kettering Cancer Center |
1998-12 | PHASE2 |
| NCT00003050 | COMPLETED | Breast Cancer |
University of Southern California |
1997-04 | PHASE2 |
| NCT00004014 | COMPLETED | Prostate Cancer |
Case Comprehensive Cancer Center |
1999-04 | PHASE2 |
| NCT00006669 | WITHDRAWN | Lymphoma |
Medstar Health Research Institute |
1999-09 | PHASE2 |
| NCT00002993 | TERMINATED | Sarcoma |
Gynecologic Oncology Group |
1997-08 | PHASE2 |
| NCT00004039 | WITHDRAWN | Lymphoma |
Hoag Memorial Hospital Presbyterian |
1998-06 | PHASE2 |
| NCT00379041 | ACTIVE_NOT_RECRUITING | Lymphoma |
European Organisation for Research and Treatment of Cancer - EORTC |
1993-09-01 | PHASE3 |
| NCT00590785 | COMPLETED | High Risk; Breast Cancer; Positive Nodes; Cyclophosphamide; Doxorubicin |
National Cancer Institute (NCI) |
1996-08-13 | PHASE3 |
| NCT00002526 | COMPLETED | Ovarian Cancer; Sarcoma |
Swiss Cancer Institute |
1993-01 | PHASE2 |
| NCT00645632 | COMPLETED | Sarcoma |
Mayo Clinic |
1990-11 | |
| NCT00003364 | COMPLETED | Lung Cancer |
London Lung Cancer Group |
1993-01 | PHASE3 |
| NCT00003578 | UNKNOWN | Lymphoma |
Lymphoma Trials Office |
1993-01 | PHASE3 |
| NCT00216645 | COMPLETED | Ovarian Neoplasms |
Janssen Pharmaceutical K.K. |
2005-01 | PHASE2 |
| NCT00002653 | UNKNOWN | Multiple Myeloma and Plasma Cell Neoplasm |
Medical Research Council |
1993-09 | PHASE3 |
| NCT00002557 | UNKNOWN | Lymphoma |
National Cancer Institute (NCI) |
1993-06 | PHASE2 |
| NCT00003243 | COMPLETED | Leukemia; Lymphoma; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
1998-01 | PHASE1 |
| NCT00025610 | COMPLETED | Neuroblastoma |
European Infant Neuroblastoma Study Group - 1999 |
1999-07 | PHASE2 |
| NCT00002582 | COMPLETED | Breast Cancer |
Institute of Cancer Research, United Kingdom |
1993-06 | PHASE3 |
| NCT00000689 | COMPLETED | Lymphoma, Non-Hodgkin; HIV Infections |
National Institute of Allergy and Infectious Diseases (NIAID) |
PHASE1 | |
| NCT00019630 | COMPLETED | Childhood Soft Tissue Sarcoma; Childhood Liver Cancer; Bone Cancer; Brain Tumor; Kidney Tumor |
National Cancer Institute (NCI) |
1999-07 | PHASE1 |
| NCT00023738 | COMPLETED | Sarcoma |
Radiation Therapy Oncology Group |
2001-08 | PHASE1; PHASE2 |
| NCT00003912 | COMPLETED | Liver Cancer |
Societe Internationale d'Oncologie Pediatrique |
1998-06 | PHASE3 |
| NCT00079027 | UNKNOWN | Liver Cancer |
University Hospital Birmingham |
2004-04 | PHASE3 |
| NCT00689845 | UNKNOWN | Lymphoma |
University Hospital Southampton NHS Foundation Trust |
2007-06 | |
| NCT00002599 | UNKNOWN | Multiple Myeloma and Plasma Cell Neoplasm |
Medical Research Council |
1994-09 | PHASE3 |
| NCT00201318 | COMPLETED | Non-Hodgkin's Lymphoma |
National Health Research Institutes, Taiwan |
2001-09 | PHASE2 |
| NCT00017225 | COMPLETED | Neuroblastoma |
German Society for Pediatric Oncology and Hematology GPOH gGmbH |
1997-05 | PHASE2 |
| NCT00006433 | UNKNOWN | Breast Cancer |
National Center for Research Resources (NCRR) |
2000-01 | PHASE2 |
| NCT00002516 | UNKNOWN | Sarcoma |
University Hospital Muenster |
1992-07 | PHASE3 |
| NCT00159094 | UNKNOWN | Metastatic Breast Cancer |
Hematology Oncology Consultants |
2003-10 | PHASE2 |
| NCT00525642 | UNKNOWN | Breast Neoplasms; Adjuvant; Chemotherapy |
Fudan University |
2003-06 | PHASE2; PHASE3 |
| NCT00436709 | UNKNOWN | Breast Cancer |
Memorial Sloan Kettering Cancer Center |
2006-07 | |
| NCT00004218 | COMPLETED | Leukemia |
Leukemia Research Fund |
1999-10 | PHASE3 |
| NCT00028886 | UNKNOWN | Multiple Myeloma and Plasma Cell Neoplasm |
Commissie Voor Klinisch Toegepast Onderzoek |
2001-03 | PHASE3 |
| NCT00801411 | UNKNOWN | Breast Cancer |
National Cancer Centre, Singapore |
2008-10 | PHASE2 |
| NCT00070447 | COMPLETED | Lymphoma |
National Cancer Institute (NCI) |
2003-11 | PHASE2 |
| NCT00005024 | UNKNOWN | Unspecified Adult Solid Tumor, Protocol Specific |
Jonsson Comprehensive Cancer Center |
PHASE3 | |
| NCT00002319 | COMPLETED | Sarcoma, Kaposi; HIV Infections |
Sequus Pharmaceuticals |
PHASE3 | |
| NCT00012311 | UNKNOWN | Breast Cancer |
Herbert Irving Comprehensive Cancer Center |
2000-01 | PHASE2 |
| NCT00309920 | UNKNOWN | Breast Cancer |
Heinrich-Heine University, Duesseldorf |
2004-01 | |
| NCT00002147 | COMPLETED | Sarcoma, Kaposi; HIV Infections |
Sequus Pharmaceuticals |
PHASE3 | |
| NCT00002318 | UNKNOWN | Sarcoma, Kaposi; HIV Infections |
Sequus Pharmaceuticals |
PHASE3 | |
| NCT00041210 | UNKNOWN | Lymphoma |
Mount Vernon Cancer Centre at Mount Vernon Hospital |
2001-10 | PHASE3 |
| NCT00028717 | UNKNOWN | Lymphoma |
Commissie Voor Klinisch Toegepast Onderzoek |
2001-02 | PHASE3 |
| NCT00001339 | COMPLETED | Adrenal Cortical Carcinoma |
National Cancer Institute (NCI) |
1993-08 | PHASE2 |
| NCT00110006 | WITHDRAWN | Lymphoma |
Case Comprehensive Cancer Center |
2004-12 | |
| NCT00000987 | COMPLETED | Sarcoma, Kaposi; HIV Infections |
National Institute of Allergy and Infectious Diseases (NIAID) |
PHASE1 | |
| NCT00002477 | UNKNOWN | Ovarian Cancer |
Medical Research Council |
1991-04 | PHASE3 |
| NCT00002093 | COMPLETED | Sarcoma, Kaposi; HIV Infections |
Nexstar Pharmaceuticals |
PHASE3 | |
| NCT00041808 | COMPLETED | Metastases, Neoplasm; Colorectal Neoplasms; Esophageal Neoplasms; Stomach Neoplasms; Pancreatic Neoplasms; Breast Neoplasms; Melanoma; Sarcoma; Gastrointestinal Neoplasms; Lung Neoplasms; Liver Neoplasms; Cholangiocarcinoma |
FeRx |
2001-07 | PHASE1; PHASE2 |
| NCT00054951 | UNKNOWN | Hepatocellular Carcinoma |
FeRx |
2001-06 | PHASE1; PHASE2 |
| NCT00471484 | UNKNOWN | Liver Cancer |
National Cancer Centre, Singapore |
2007-03 | PHASE2 |
| NCT00003421 | COMPLETED | Lymphoma |
Medical Research Council |
1998-06 | PHASE3 |
| NCT00025649 | COMPLETED | Neuroblastoma |
European Infant Neuroblastoma Study Group - 1999 |
1999-07 | PHASE2 |
| NCT00417053 | UNKNOWN | Neuroblastoma |
Children's Cancer and Leukaemia Group |
PHASE3 | |
| NCT00003172 | COMPLETED | Gastric Cancer |
Eastern Cooperative Oncology Group |
1997-12 | PHASE2 |
| NCT00343369 | UNKNOWN | Leukemia |
Universitätsklinikum Hamburg-Eppendorf |
2003-01 | |
| NCT00124956 | WITHDRAWN | Cancer |
Boston Children's Hospital |
2003-06 | PHASE1; PHASE2 |
| NCT00000954 | COMPLETED | Sarcoma, Kaposi; HIV Infections |
National Institute of Allergy and Infectious Diseases (NIAID) |
PHASE1 | |
| NCT00020124 | COMPLETED | Lung Cancer; Malignant Mesothelioma; Metastatic Cancer |
National Institutes of Health Clinical Center (CC) |
2000-06 | PHASE1 |
| NCT00005583 | COMPLETED | Endometrial Cancer |
Nordic Society of Gynaecological Oncology - Clinical Trials Unit |
2000-01 | PHASE3 |
| NCT00025428 | COMPLETED | Neuroblastoma |
Societe Internationale d'Oncologie Pediatrique |
2000-12 | PHASE3 |
| NCT00003493 | COMPLETED | Multiple Myeloma and Plasma Cell Neoplasm |
The Cleveland Clinic |
1998-11 | PHASE2 |
| NCT00025441 | COMPLETED | Ovarian Cancer; Sarcoma; Small Intestine Cancer |
Societe Internationale d'Oncologie Pediatrique |
1998-11 | PHASE2 |
| NCT00115414 | COMPLETED | Breast Cancer; Fever; Neutropenia |
Amgen |
PHASE2 | |
| NCT00416377 | UNKNOWN | Lymphoma |
Children's Cancer and Leukaemia Group |
||
| NCT00061867 | COMPLETED | Prostate Cancer |
Imunon |
2003-03 | PHASE1 |
| NCT00025064 | UNKNOWN | Lymphoma |
Children's Cancer and Leukaemia Group |
2000-01 | PHASE2 |
| NCT00004237 | COMPLETED | Breast Cancer |
Royal Marsden NHS Foundation Trust |
1998-10 | PHASE2 |
| NCT00003696 | UNKNOWN | Lung Cancer |
Commissie Voor Klinisch Toegepast Onderzoek |
1998-10 | PHASE3 |
| NCT00022945 | COMPLETED | Mantle Cell Lymphoma |
Corixa Corporation |
PHASE2 | |
| NCT00132756 | TERMINATED | Prostate Cancer |
Morton Plant Mease Health Care |
2003-12 | PHASE1; PHASE2 |
| NCT00004236 | UNKNOWN | Esophageal Cancer; Gastric Cancer |
University of Leicester |
1998-08 | PHASE2 |
| NCT00024271 | UNKNOWN | Malignant Mesothelioma |
Herbert Irving Comprehensive Cancer Center |
2001-05 | PHASE2 |
| NCT00031187 | COMPLETED | Prostatic Neoplasms |
Seagen Inc. |
2000-10 | PHASE2 |
| NCT00310089 | COMPLETED | Breast Cancer |
National Cancer Institute (NCI) |
2006-01 | |
| NCT00102609 | COMPLETED | Soft Tissue Sarcoma; Sarcoma; Neoplasms, Connective and Soft Tissue; Neoplasms by Histologic Type; Neoplasms |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
2005-04 | PHASE1 |
| NCT00000658 | COMPLETED | Lymphoma, Non-Hodgkin; HIV Infections |
National Institute of Allergy and Infectious Diseases (NIAID) |
PHASE3 | |
| NCT00003296 | UNKNOWN | Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Liver Cancer |
Brown University |
1998-01 | PHASE2 |
| NCT00005959 | UNKNOWN | Lymphoma |
Amgen |
1999-12 | PHASE2 |
| NCT00002696 | SUSPENDED | Breast Cancer |
Grupo Oncologico Cooperativo del Sur |
1995-10 | PHASE3 |
| NCT00018954 | COMPLETED | Leukemia; Lymphoma |
National Institutes of Health Clinical Center (CC) |
1992-10 | PHASE2 |
| NCT00536393 | COMPLETED | Lymphoma |
French Innovative Leukemia Organisation |
2000-10 | PHASE2; PHASE3 |
| NCT00344422 | COMPLETED | Multiple Myeloma; Myeloma; M-Protein; Myeloma Proteins |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
2000-10 | PHASE3 |
| NCT00000626 | COMPLETED | HIV Infections; Hodgkin's Disease |
National Institute of Allergy and Infectious Diseases (NIAID) |
PHASE2 | |
| NCT00003893 | COMPLETED | Breast Cancer |
University Hospital Birmingham |
1998-07 | PHASE3 |
| NCT00080925 | COMPLETED | Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms |
National Institutes of Health Clinical Center (CC) |
2004-02 | PHASE1 |
| NCT00003437 | UNKNOWN | Leukemia |
Medical Research Council |
1997-01 | PHASE3 |
| NCT00006232 | COMPLETED | Multiple Myeloma and Plasma Cell Neoplasm |
West of Scotland Lymphoma Group |
1996-10 | PHASE3 |
| NCT00052351 | COMPLETED | Breast Cancer |
National Cancer Institute (NCI) |
2002-09 | PHASE2 |
| NCT00025623 | COMPLETED | Neuroblastoma |
European Infant Neuroblastoma Study Group - 1999 |
1999-07 | PHASE2 |
| NCT00669812 | UNKNOWN | Lymphoma; Small Intestine Cancer |
Cancer Research UK |
2008-02 | PHASE2 |
| NCT00077389 | UNKNOWN | Liver Cancer |
University of Leicester |
2004-01 | PHASE2 |
| NCT00002531 | UNKNOWN | Leukemia |
Johann Wolfgang Goethe University Hospital |
1993-01 | PHASE2 |
| NCT00003052 | COMPLETED | Sarcoma |
European Organisation for Research and Treatment of Cancer - EORTC |
1997-07 | PHASE3 |
| NCT00434031 | WITHDRAWN | Breast Cancer |
National Cancer Institute, Naples |
2007-09 | PHASE2 |
| NCT00003262 | UNKNOWN | Lymphoma |
Centro di Riferimento Oncologico - Aviano |
1997-05 | PHASE2 |
| NCT00217503 | COMPLETED | Lymphoma |
National Cancer Institute (NCI) |
2005-07 | PHASE2 |
| NCT01490047 | WITHDRAWN | Solid Tumors; Lymphomas |
Ludwig Institute for Cancer Research |
2013-01 | PHASE1 |
| NCT00044993 | COMPLETED | Breast Cancer |
Introgen Therapeutics |
2002-02 | PHASE2 |
| NCT00002755 | COMPLETED | Breast Cancer |
Scottish Cancer Therapy Network |
1995-11 | PHASE3 |
| NCT00002987 | UNKNOWN | Lymphoma |
Medical Research Council |
1997-01 | PHASE3 |
| NCT00003679 | UNKNOWN | Breast Cancer |
Scottish Cancer Therapy Network |
1998-11 | PHASE3 |
(data from https://clinicaltrials.gov, updated on 2026-06-11)
Check the
Doxorubicin (Adriamycin) Hydrochloride
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
Mechanism and Biochemical Profile
Appendix RUO and cGMP Quality Standards
| Quality Dimension | RUO (Research Use Only) | cGMP (Current Good Manufacturing Practice) |
|---|---|---|
| Clinical Applicability | Prohibited in human clinical trials or medical diagnostics. | Mandatory for human clinical trials (Phase I–III) and therapies. |
| Regulatory Status | Non-regulated grade; exempt from drug manufacturing laws. | Legally enforced by health authorities (e.g., FDA, EMA, NMPA). |
| Facility Environment | Unclassified analytical or research laboratories. | Validated Cleanrooms (ISO Class 5–8) with continuous monitoring. |
| Quality Control | Basic purity and activity testing. | Rigorous safety release testing (Sterility, Endotoxin, Mycoplasma). |
| Process Validation | Basic equipment calibration; no process validation required. | Full qualification (IQ/OQ/PQ) and complete batch records. |
| Quality Assurance | Vendor self-declared without required formal QMS. | Mandatory QA/QC unit, Change Control, CAPA, and vendor audits. |
| Regulatory Impact | High risk of IND rejection if used as a critical raw material. | Required for IND/NDA filings, supported by Drug Master Files (DMF). |
Footnotes
Regulatory Note: Governed by FDA (21 CFR Parts 210/211/312), EMA (EudraLex Vol 4), ICH Guidelines (E6/Q7/Q9/Q10), and compendial standards (USP <71>/<85>/<1043>).
- Doxorubicin (Adriamycin) Hydrochloride Mechanism of Action: Topoisomerase II beta Inhibition in Cardiomyocyte Research
- Doxorubicin (Adriamycin) Hydrochloride: Selectivity & Specificity
- Doxorubicin (Adriamycin) Hydrochloride Working Concentration | Cell Culture | Treatment
- Doxorubicin (Adriamycin) Hydrochloride Solubility in DMSO
- Doxorubicin (Adriamycin) Hydrochloride Stock Solution
- Doxorubicin (Adriamycin) Hydrochloride Storage
- Doxorubicin (Adriamycin) Hydrochloride Stability
- Doxorubicin (Adriamycin) Hydrochloride Combination Database
- Doxorubicin (Adriamycin) Hydrochloride Molecular Weight
- Doxorubicin (Adriamycin) Hydrochloride SMILES
- Doxorubicin (Adriamycin) Hydrochloride CAS Number
- Doxorubicin (Adriamycin) Hydrochloride Chemical Structure (2D and 3D)
- Doxorubicin (Adriamycin) Hydrochloride IC50 for Cell-based and Cell-free Assays
- Doxorubicin (Adriamycin) Hydrochloride Sigma (D1515)? Try a better option.
- Doxorubicin (Adriamycin) Hydrochloride MedChemExpress (HY-15142)? Try a better option.
- Doxorubicin (Adriamycin) Hydrochloride Cayman (15007)? Try a better option.
- Doxorubicin (Adriamycin) Hydrochloride Tocris (2252)? Try a better option.
- Doxorubicin (Adriamycin) Hydrochloride Abcam (ab120629)? Try a better option.
- Doxorubicin (Adriamycin) Hydrochloride SDS｜MSDS
Note: Technical data last updated: Sep 1, 2026.